<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Thermal stability and storage of human insulin - Richter, B - 2023 | Cochrane Library</title> <meta content="Thermal stability and storage of human insulin - Richter, B - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Thermal stability and storage of human insulin - Richter, B - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD015385.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Thermal stability and storage of human insulin" name="citation_title"/> <meta content="Bernd Richter" name="citation_author"/> <meta content="Institute of General Practice, Medical Faculty of the Heinrich-Heine-University" name="citation_author_institution"/> <meta content="richterb@uni-duesseldorf.de" name="citation_author_email"/> <meta content="Brenda Bongaerts" name="citation_author"/> <meta content="Institute of General Practice, Medical Faculty of the Heinrich-Heine-University" name="citation_author_institution"/> <meta content="Maria-Inti Metzendorf" name="citation_author"/> <meta content="Institute of General Practice, Medical Faculty of the Heinrich-Heine-University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD015385.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/11/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015385.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Drug Stability; *Drug Storage; *Insulin; Temperature" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015385.pub2&amp;doi=10.1002/14651858.CD015385.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD015385\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD015385\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","pt","ms","ja","hr","fa","id","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD015385.pub2",title:"Thermal stability and storage of human insulin",firstPublishedDate:"Nov 6, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015385.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD015385.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD015385.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD015385.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015385.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD015385.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD015385.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD015385.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD015385.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD015385.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9490 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD015385.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0094"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0011"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0012"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0032"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-sec-0088"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/appendices#CD015385-sec-0099"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/supinfo/CD015385-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/supinfo/CD015385-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Prototype</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Thermal stability and storage of human insulin</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information#CD015385-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Bernd Richter</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information#CD015385-cr-0005">Brenda Bongaerts</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information#CD015385-cr-0006">Maria-Inti Metzendorf</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information/en#CD015385-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 November 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD015385.pub2">https://doi.org/10.1002/14651858.CD015385.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD015385-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD015385-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD015385-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD015385-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD015385-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD015385-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD015385-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD015385-abs-0001" lang="en"> <section id="CD015385-sec-0001"> <h3 class="title" id="CD015385-sec-0001">Background</h3> <p>Health authorities stress the temperature sensitivity of human insulin, advising protection from heat and freezing, with manufacturers suggesting low‐temperature storage for intact vials, and once opened, storage at room temperature for four to six weeks, though usage time and maximum temperature recommendations vary. For human insulin, the recommendations of current shelf life in use may range from 10 to 45 days, and the maximum temperature in use varies between 25 °C and 37 °C. Optimal cold‐chain management of human insulin from manufacturing until the point of delivery to people with diabetes should always be maintained, and people with diabetes and access to reliable refrigeration should follow manufacturers' recommendations. However, a growing segment of the diabetes‐affected global population resides in challenging environments, confronting prolonged exposure to extreme heat due to the climate crisis, all while grappling with limited access to refrigeration. </p> </section> <section id="CD015385-sec-0002"> <h3 class="title" id="CD015385-sec-0002">Objectives</h3> <p>To analyse the effects of storing human insulin above or below the manufacturers' recommended insulin temperature storage range or advised usage time, or both, after dispensing human insulin to people with diabetes. </p> </section> <section id="CD015385-sec-0003"> <h3 class="title" id="CD015385-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 12 July 2023. </p> </section> <section id="CD015385-sec-0004"> <h3 class="title" id="CD015385-sec-0004">Selection criteria</h3> <p>We included clinical and laboratory studies investigating the storage of human insulin above or below manufacturers' recommended temperature storage range, advised usage time, or both. </p> </section> <section id="CD015385-sec-0005"> <h3 class="title" id="CD015385-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. We used GRADE to assess the certainty of evidence for the clinical study. Most information emerged from in vitro studies, mainly from pharmaceutical companies. There is no validated risk of bias and certainty of evidence rating for in vitro studies. We thus presented a narrative summary of the results. </p> </section> <section id="CD015385-sec-0006"> <h3 class="title" id="CD015385-sec-0006">Main results</h3> <p>We included 17 eligible studies (22 articles) and additional information from pharmaceutical companies. </p> <p><b>Pilot clinical study</b> </p> <p>One pilot clinical study investigated temperature conditions for insulin stored for six weeks in an unglazed clay pot with temperatures ranging between 25 °C and 27 °C. The mean fall in plasma glucose in eight healthy volunteers after clay pot‐stored insulin injection was comparable to refrigerator‐stored insulin injection (very low‐certainty evidence). </p> <p><b>In‐vitro studies</b> </p> <p>Nine, three and four laboratory studies investigated storage conditions for insulin vials, insulin cartridges/pens and prefilled plastic syringes, respectively. The included studies reported numerous methods, laboratory measurements and storage conditions. </p> <p>Three studies on prefilled syringes investigating insulin potency at 4 °C up to 23 °C for up to 28 days showed no clinically relevant loss of insulin activity. </p> <p>Nine studies examined unopened vials and cartridges. In studies with no clinically relevant loss of insulin activity for human short‐acting insulin (SAI), intermediate‐acting insulin (IAI) and mixed insulin (MI) temperatures ranged between 28.9 °C and 37 °C for up to four months. Two studies reported up to 18% loss of insulin activity after one week to 28 days at 37 °C. Four studies examined opened vials and cartridges at up to 37 °C for up to 12 weeks, indicating no clinically relevant reduction in insulin activity. Two studies analysed storage conditions for oscillating temperatures ranging between 25 °C and 37 °C for up to 12 weeks and observed no loss of insulin activity for SAI, IAI and MI. Four studies, two on vials (including one on opened vials), and two on prefilled syringes, investigated sterility and reported no microbial contamination. </p> <p><b>Data from pharmaceutical companies</b> </p> <p>Four manufacturers (BIOTON, Eli Lilly and Company, Novo Nordisk and Sanofi) provided previously unreleased human insulin thermostability data mostly referring to unopened containers (vials, cartridges). We could not include the data from Sanofi because the company announced the permanent discontinuation of the production of human insulins Insuman Rapid, Basal and Comb 25. </p> <p>BIOTON provided data on SAI after one, three and six months at 25 °C: all investigated parameters were within reference values, and, compared to baseline, loss of insulin activity was 1.1%, 1.0% and 1.7%, respectively. </p> <p>Eli Lilly and Company provided summary data: at below 25 °C or 30 °C SAI/IAI/MI could be stored for up to 25 days or 12 days, respectively. Thereafter, patient in‐use was possible for up to 28 days. </p> <p>Novo Nordisk provided extensive data: compared to baseline, after three and six months at 25 °C, loss of SAI activity was 1.8% and 3.2% to 3.5%, respectively. Loss of IAI activity was 1.2% to 1.9% after three months and 2.0% to 2.3% after six months. Compared to baseline, after one, two and three months at 37 °C, loss of SAI activity was 2.2% to 2.8%, 5.7% and 8.3% to 8.6%, respectively. Loss IAI activity was 1.4% to 1.8%, 3.0% to 3.8% and 4.7% to 5.3%, respectively. There was no relevant increase in insulin degradation products observed. Up to six months at 25 °C and up to two months at 37 °C high molecular weight proteins were within specifications. Appearance, visible particles or macroscopy, particulate matter, zinc, pH, metacresol and phenol complied with specifications. </p> <p>There were no data for cold environmental conditions and insulin pumps.</p> </section> <section id="CD015385-sec-0007"> <h3 class="title" id="CD015385-sec-0007">Authors' conclusions</h3> <p>Under difficult living conditions, pharmaceutical companies' data indicate that it is possible to store unopened SAI and IAI vials and cartridges at up to 25 °C for a maximum of six months and at up to 37 °C for a maximum of two months without a clinically relevant loss of insulin potency. Also, oscillating temperatures between 25 °C and 37 °C for up to three months result in no loss of insulin activity for SAI, IAI and MI. In addition, ambient temperature can be lowered by use of simple cooling devices such as clay pots for insulin storage. Clinical studies on opened and unopened insulin containers should be performed to measure insulin potency and stability after varying storage conditions. Furthermore, more data are needed on MI, insulin pumps, sterility and cold climate conditions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD015385-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD015385-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD015385-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD015385-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD015385-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD015385-abs-0017">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD015385-abs-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/id#CD015385-abs-0015">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD015385-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD015385-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD015385-abs-0009">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD015385-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD015385-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD015385-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD015385-abs-0002" lang="en"> <h3>Temperature and storage conditions for human insulin</h3> <p><b>What is insulin?</b> </p> <p>Insulin is a hormone made by the pancreas that helps your body turn food into energy and controls your blood sugar levels. People with diabetes cannot make enough insulin or use it effectively, so some have to inject it themselves. </p> <p><b>How should insulin be stored?</b> </p> <p>Health authorities and pharmaceutical manufacturers recommend keeping insulin away from sunlight, not freezing it and storing it in a refrigerator. Unopened human insulin vials or flasks and cartridges for insulin pens should be stored at temperatures between 2 °C and 8 °C, which requires reliable refrigeration. Once opened, vials or cartridges can be stored at 'room temperature' and used for approximately four to six weeks. However, recommendations differ regarding usage time and maximum temperature once open (in‐use insulin). Also, advice varies for the type of insulin, brand, insulin concentrations and container (vial, cartridge/pen, insulin pump). Regulatory bodies guide how to handle insulin transport and storage temperature ('cold chain') from manufacturer to delivery to people with diabetes. If reliable refrigeration is available, people with diabetes should store insulin according to official recommendations. However, there is no clear consensus on how human insulin should be stored at home if reliable refrigeration cannot be guaranteed. </p> <p><b>What are the problems with insulin storage?</b> </p> <p>Many people with diabetes live in settings with little access to healthcare facilities and refrigeration. Challenging locations affected by natural disasters, periods of extreme heat due to the climate crisis or war‐like conditions additionally complicate appropriate insulin storage. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to analyse the effects of storing human insulin above or below the manufacturers' recommended insulin temperature or advised usage time, or both. </p> <p><b>What did we look for?</b> </p> <p>We searched medical databases and contacted study authors and pharmaceutical manufacturers about studies on people with diabetes. We also looked for laboratory studies investigating the effects of storing human insulin above or below the manufacturers' recommended insulin temperature storage range or advised usage time, or both. </p> <p><b>What did we find?</b> </p> <p>We found one clinical study. Nine, three and four laboratory studies investigated storage conditions for insulin vials, insulin cartridges and prefilled plastic insulin syringes, respectively. </p> <p><b>Key results</b> </p> <p>In the clinical study, authors investigated insulin stored for six weeks in an unglazed clay pot or in a refrigerator. Outside temperatures were between 34 °C and 43 °C, and clay pot temperatures were between 25 °C and 27 °C. The study authors only reported on the glucose level in the blood of eight healthy volunteers after injecting clay‐pot‐stored insulin or refrigerator‐stored insulin. Insulin in the clay pot had similar glucose‐lowering activity to insulin in a refrigerator. </p> <p>Laboratory studies on prefilled syringes stored at 4 °C to 23 °C for up to 28 days showed no clinically relevant loss of insulin activity. </p> <p>Nine laboratory studies examined unopened vials and cartridges. In studies with no clinically relevant loss of insulin activity, temperatures ranged between 28.9 °C and 37 °C for up to four months. Two studies reported a more pronounced loss of insulin activity after one week to 28 days at 37 °C. Four studies examined opened vials and cartridges at up to 37 °C for up to 12 weeks, and showed no clinically relevant reduction in insulin activity. </p> <p>Two laboratory studies analysed storage conditions for shifting temperatures between 25 °C and 37 °C up to 12 weeks, resembling daytime and night‐time fluctuations in tropical countries. There was no loss of insulin activity for short‐acting, intermediate‐acting and mixed insulin (a combination of short‐acting and intermediate‐acting human insulin). </p> <p>Four laboratory studies, two on vials, one of them on opened vials, and two on prefilled syringes, investigated sterility and reported no bacterial contamination. </p> <p>Four manufacturers provided previously unpublished temperature and storage conditions data. If unopened human insulin vials or cartridges were stored at up to 25 °C for a maximum of six months or at up to 37 °C for a maximum of two months, only small amounts of insulin activity were lost. We could not include the provided data from the manufacturer Sanofi because the company announced the permanent discontinuation of the production of human insulins called Insuman Rapid, Basal and Comb 25. </p> <p>If no reliable refrigeration is possible, room temperature can be lowered using simple cooling devices such as clay pots for insulin storage. </p> <p>There were no data for cold environmental conditions or insulin pumps.</p> <p><b>What are the limitations of the evidence?</b> </p> <p>Data on the quality of human insulin in unopened vials and cartridges appeared reliable. However, most data came from laboratory studies, and we were unable to assess the certainty of evidence because there are currently no validated methods for doing so. More studies should investigate the possible bacterial contamination risk of in‐use insulin vials and cartridges. Also, clinical studies in particular are needed to inform on temperature and storing conditions for insulin outside the official recommendations. </p> <p><b>How up to date is this review?</b> </p> <p>This evidence is up to date as of 12 July 2023.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD015385-sec-0094" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD015385-sec-0094"></div> <section id="CD015385-sec-0095"> <h3 class="title" id="CD015385-sec-0095">Implications for practice</h3> <p>An increasing portion of the global diabetes community resides in settings with poor or no access to healthcare facilities and refrigeration. In these circumstances, pharmaceutical companies' data indicate that it is possible to store unopened short‐acting and intermediate‐acting human insulin vials or cartridges at up to 25 °C for a maximum of six months and at up to 37 °C for a maximum of two months without a clinically relevant loss of insulin potency. Also, oscillating temperatures between 25 °C and 37 °C, resembling daytime and night‐time fluctuations in tropical countries, for up to three months do not result in a clinically relevant loss of insulin activity of short‐acting, intermediate‐acting and mixed human insulin. With the help of simple cooling devices for insulin storage such as clay pots, it is possible to effectively reduce high outside temperatures in many high‐temperature regions of the world. </p> </section> <section id="CD015385-sec-0096"> <h3 class="title" id="CD015385-sec-0096">Implications for research</h3> <p>Since there are few clinical studies on the thermostability of human insulin to date, clamp studies and other clinical studies allowing the investigation of insulin pharmacodynamics should be performed to measure insulin potency and safety after varying storage conditions in human volunteers and people with diabetes. More studies are needed on mixed insulin, as well as on opened vials and cartridges to investigate potential microbial ingress risk after multiple punctures of the container. Finally, studies on cold environmental conditions and insulin pumps are required. </p> <p>On 22 April 2022, Novo Nordisk announced that the European Medicines Agency (EMA) has issued the company a positive scientific opinion for a proposed update of the storage conditions of two human insulins: "EMA's positive scientific opinion will now be used to support approval of the more flexible storage conditions by national health authorities in a number of relevant low‐ and middle‐income countries. This is to allow Actrapid (short‐acting insulin), and Insulatard (intermediate‐acting insulin) can be stored for four weeks outside a refrigerator (if kept below 30 °C) prior to use if there are six months or more to the expiry date. Once in use, the insulin should be stored without refrigeration." Other manufacturers of human insulin should also contact drug approval authorities and make thermostability data available to establish better real‐life updates on storage recommendations of human insulin. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD015385-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD015385-sec-0008"></div> <div class="table" id="CD015385-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Clinical studies</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> healthy physicians<br/><b>Setting:</b> outpatients, opened vials<br/><b>Intervention:</b> neutral human insulin, stored in a refrigerator at 4 °C<br/><b>Comparison:</b> neutral human insulin, stored in a zeer<sup>a</sup> at a mean of 26.6 °C </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>№ of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Effect</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Potency/bioactivity parameters of human insulin</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diabetic ketoacidosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Hypoglycaemic episodes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Health‐related quality of life</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HbA1c</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean fall in plasma glucose levels</b> (mmol/L/min) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous injection of 0.1 U/kg bodyweight of human insulin with blood samples taken every 5 min up to 30 min following the injection. </p> <p>Refrigerator insulin (mean 4 °C, 6 weeks' storage): 0.213 mmol/L/min</p> <p>Zeer‐stored insulin (mean 26.6 °C, 6 weeks' storage): 0.192 mmol/L/min</p> <p>Quote: "The observed difference in the rate of decline of glucose following insulin stored in a zeer, and that … being stored in a refrigerator, was not statistically significant." </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>HbA1c:</b> glycosylated haemoglobin A1c; <b>min:</b> minute; <b>RCT:</b> randomised controlled trial; <b>U:</b> unit. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Zeer: a clay pot that was unglazed, enabling water to slowly seep through the wall and evaporate, thus lowering the temperature of the remaining water. A glass jar with partially filled desert sand was put in the centre of the zeer. A water bath was created by adding water outside the jar to the same level as that of the sand in the glass jar. Water was added to the mark (topped up) daily. The zeer was closed with a clay lid and kept in the shade.<br/><sup>b</sup>Downgraded three levels due to the risk of bias (unclear randomisation and allocation concealment), indirectness (surrogate outcome, insufficient time frame) and imprecision (very small sample size, one study only). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD015385-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Published in‐vitro studies</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: insulin potency<sup>a</sup> measured by HPLC (mean % change compared to baseline)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 °C / 37 °C (28 days): −14% / −18%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 °C / 37 °C (28 days)<sup>b</sup>: −11% / −14% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probably unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): +0.1% / +1.3%<br/>37 °C<sup>d</sup> (2 weeks): −12.5% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): +1.3% / +1.6%<br/>31 °C<sup>d</sup> (1 / 4 / 8 weeks): +0.2% / −5.2% / −17.2% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): +0.6% / +1.9% </p> <p>37 °C<sup>d</sup> (1 week): −15.4% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): −0.7% / −2.0% / −2.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): +2.1% / −1.7% / −0.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): +0.8% / −1.8% / −1.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): −1.5% to + 0.6%</p> <p>23 °C (28 days): −1.9% to +1.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): +1.0% to +2.5%</p> <p>23 °C (28 days): +0.7% to +4.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): −0.2% to 2.4%</p> <p>23 °C (28 days): −1.0% to −1.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: insulin potency<sup>a</sup> measured by HPLC, mass spectrometry, radioimmunological activity</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shaken for 72 hours at 37 °C and at ambient temperature: same molecular insulin weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (26 weeks): −0.069% total protein/week<br/>37 °C (26 weeks): –1.184% total protein/week<br/>Direct sunlight (26 weeks): −0.749% total protein/week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22–24 °C (42 days): 12 min peak 93% of baseline AUC reference; 21 min peak 94% of baseline AUC reference </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 °C (6 weeks): −3.1 IU/mL (95% CI 4.0)<br/>30 °C (10 weeks): −4.0 IU/mL (95% CI 4.9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 °C (6 weeks): −1.0 IU/mL (95% CI 1.9)<br/>30 °C (10 weeks): −1.4 IU/mL (95% CI 2.3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (86 days): 98.6 U/mL (CV 5.5%)<br/>22 °C (86 days): 99.4 U/mL (CV 5%)<br/>37 °C (86 days): 98.7 U/mL (CV 4.6%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> and 37 °C<sup>d</sup> (28 days): potency within specifications </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> and 37 °C<sup>d</sup> (28 days): potency within specifications; agglomerates (37 °C<sup>d</sup>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> and 37 °C<sup>d</sup> (28 days): potency within specifications; agglomerates (37 °C<sup>d</sup>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.7 °C (28 days): −2.6% to +1.4% (compared to baseline AUC)<br/>37 °C (28 days): −1.5% to +0.7% (compared to baseline AUC) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (2 weeks): no change in potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3–5 °C (28 days): 93.3% (SD 2.4) AUC of initial concentration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: protein structure, formation of amyloid material</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): tridimensional structure verified </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): tridimensional structure verified </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): tridimensional structure verified </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C and 37 °C (5 weeks): no amyloid particles, large amorphous agglomerates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C and 37 °C (5 weeks): no amyloid particles, large amorphous agglomerates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): altered conformation or multimerisation in a minor fraction of the insulin molecules </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): altered conformation or multimerisation in a minor fraction of the insulin molecules </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): altered conformation or multimerisation in a minor fraction of the insulin molecules </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C (10 weeks): small changes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: sterility, microbial contamination</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shaken for 72 hours at 37 °C and at ambient temperature: no bacterial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): no microbial contamination </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): no microbial contamination </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): no microbial contamination </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): no microbial growth</p> <p>23 °C (28 days): no microbial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): no microbial growth</p> <p>23 °C (28 days): no microbial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): no microbial growth</p> <p>23 °C (28 days): no microbial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (10 days): no bacterial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>— denotes not investigated.</p> <p><sup>a</sup>US Pharmacopeia (USP) stipulates that human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL, i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin.<br/><sup>b</sup>Concentration of the short‐acting insulin in the biphasic insulin formulation.<br/><sup>c</sup>Oscillating temperatures.<br/><sup>d</sup>Continuous temperature.<br/><sup>e</sup>Mean insulin concentration (with CV) across all measurements and 86 days.<br/>AUC: area under the curve; CI: confidence interval; CV: coefficient of variation; HPLC: high‐performance liquid chromatography; NPH: neutral protamine Hagedorn; SD: standard deviation; U: unit. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD015385-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">In‐vitro data from pharmaceutical manufacturers</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from BIOTON<sup>a, b</sup>: human insulin potency compared to baseline (mean % change (SD) of several insulin batches)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="3" rowspan="2" scope="col" valign="bottom"> <p><b>25 °C storage</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>1 month</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>3 months</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>6 months</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Short‐acting insulin (100 IU/mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>−1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>−1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>−1.7</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="3" rowspan="2" scope="col" valign="bottom"> <p><b>30 °C storage</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>28 days</b> </p> </th> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="bottom"> <p><b>42 days</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Short‐acting insulin (40 IU/mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>−2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>−2.0</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from Eli Lilly and Company<sup>c</sup>: human insulin (100 IU/mL) potency</b> </p> </th> </tr> <tr class="separated"> <td align="" class="headercell" colspan="3" rowspan="1" valign=""></td> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Storage before start use</b> </p> </th> <th align="center" class="headercell" colspan="5" rowspan="1" scope="col" valign="bottom"> <p><b>Patient in‐use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>&lt; 25 °C (short‐acting, intermediate‐acting, mixed insulin)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Up to 25 days</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>Up to 28 days</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>&lt; 30 °C (short‐acting, intermediate‐acting, mixed insulin)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Up to 12 days</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>Up to 28 days</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from Sanofi</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p>Sanofi permanently discontinued the production of its human insulins Insuman rapid 100 IU/mL, Insuman rapid SoloStar 100 IU/mL, Insuman basal 100 IU/mL, Insuman basal SoloStar 100 IU/mL, Insuman comb 25 100 IU/mL and Insuman comb 25 SoloStar 100 IU/mL worldwide. Data provided by the manufacturer could not be included in this review. </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from Novo Nordisk<sup>a, d</sup>: human insulin (100 IU/mL) potency compared to baseline (mean % change (SD) of several insulin batches)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>25 °C storage</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>1 month</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>3 months</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>6 months</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>12 months</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.4 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.5 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.8 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.8 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.5 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.2 (0.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−7.4 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−6.5 (0.5)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intermediate‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.7 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.5 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.2 (0.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.9 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−2.0 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−2.3 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.4 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−3.9 (NA)</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>37 °C storage</b> </p> </th> <th align="center" class="headercell" colspan="4" rowspan="1" scope="col" valign="bottom"> <p><b>1 month</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>2 months</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>3 months</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−2.2 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−2.8 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−5.7 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−5.7 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−8.6 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−8.3 (0.8)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intermediate‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−1.8 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−1.4 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.8 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.0 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−5.3 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.7 (NA)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup>US Pharmacopeia (USP) stipulates that human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL, i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin.<br/><sup>b</sup>A21 desamido insulin, impurities, total zinc, metacresol and pH all remained within reference values.<br/><sup>c</sup>All product quality attributes met established acceptance criteria.<br/><sup>d</sup>Up to 6 months at 25 °C and up to 2 months at 37 °C high molecular weight proteins were within specifications. Appearance, visible particles or macroscopy, particulate matter, zinc, pH, metacresol and phenol complied with specifications. No data were available on bacterial endotoxins and sterility.<br/>IU: insulin units; NA: not applicable. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD015385-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD015385-sec-0009"></div> <p>There are two major forms of diabetes, type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). T1DM results from an autoimmune process destroying the insulin‐producing beta cells (β‐cells) of the pancreas. T1DM is the major cause of diabetes in childhood and adolescence, and injections of insulin are necessary for survival. In the tenth revision of its diabetes atlas, the International Diabetes Federation (IDF) estimated that the number of people with diabetes worldwide would increase from 573 million in 2021 to 783 million in 2045, representing a 46% increase (<a href="./references#CD015385-bbs2-0121" title="International Diabetes Federation. IDF Diabetes Atlas 2021 (IDF Atlas 10th edition). diabetesatlas.org/en/resources (accessed 18 December 2021).">IDF 2021</a>). This rise is calculated to be higher in low‐ and middle‐income countries (LMIC), with projected increases of 134% in Africa (87% in the Middle East and North Africa), 68% in South‐East Asia, and 50% in South and Central America (<a href="./references#CD015385-bbs2-0121" title="International Diabetes Federation. IDF Diabetes Atlas 2021 (IDF Atlas 10th edition). diabetesatlas.org/en/resources (accessed 18 December 2021).">IDF 2021</a>). In comparison, the estimates for Europe, the Western Pacific and North America, and the Caribbean are 13%, 27% and 24%, respectively (<a href="./references#CD015385-bbs2-0121" title="International Diabetes Federation. IDF Diabetes Atlas 2021 (IDF Atlas 10th edition). diabetesatlas.org/en/resources (accessed 18 December 2021).">IDF 2021</a>). Approximately 90% of people with diabetes have T2DM, and the projected increases to 2045 are expected to be mainly due to a rising number of people with T2DM. This increase is probably caused by changes in living conditions, such as sedentary behaviour, dietary changes, obesity and other factors (<a href="./references#CD015385-bbs2-0144" title="SunH , SaeediP , KarurangaS , PinkepankM , OgurtsovaK , DuncanBB , et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice2022;183:109119. [DOI: 10.1016/j.diabres.2021.109119]">Sun 2022</a>). </p> <p>Banting and Best discovered the peptide hormone insulin in 1921; it was first used in the treatment of diabetes in 1922 and has been included in the World Health Organization's (WHO's) Model List of Essential Medicines since 1977 (<a href="./references#CD015385-bbs2-0153" title="World Health Organization. World Health Organization Model List of Essential Medicines – 22nd List (2021). apps.who.int/iris/rest/bitstreams/1374779/retrieve (accessed 15 October 2021).">WHO EML 2021</a>). T2DM accounts for approximately 90% of diabetes and is associated with insulin resistance: as a consequence of ineffective insulin action to transport glucose into cells, an increased insulin demand develops, and over time inadequate insulin production occurs due to exhaustion of pancreatic β‐cells. Several factors are related to risk of T2DM, including body composition, physical inactivity, diet, age, family history and history of gestational diabetes. It is initially treated with lifestyle modification and later on a combination of lifestyle modification and glucose‐lowering drugs (<a href="./references#CD015385-bbs2-0152" title="World Health Organization. Diagnosis and management of type 2 diabetes. apps.who.int/iris/rest/bitstreams/1274478/retrieve (accessed 11 August 2023).">WHO 2020</a>). At some point, insulin may be needed to improve diabetes management further, in case pancreatic β‐cells are unable to compensate for the increased insulin demand. The need for insulin worldwide to treat T2DM is expected to increase by more than 20% from 2018 to 2030 (<a href="./references#CD015385-bbs2-0090" title="BasuS , YudkinJS , KehlenbrinkS , DaviesJI , WildSH , LipskaKJ , et al. Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis. Lancet Diabetes Endocrinology2019;7(1):25-33. [DOI: 10.1016/S2213-8587(18)30303-6]">Basu 2019</a>). Diabetes may also occur during pregnancy (gestational diabetes) or may develop because of diseases of the pancreas, endocrine diseases, infections, drugs, immune disorders or genetic syndromes. </p> <p>Even 100 years after its discovery, access to insulin still remains a challenge for many people around the globe. Barriers to access mainly relate to affordability and availability, with costs also related to associated necessary medical devices (e.g. test strips, syringes, pens), placing a large burden on people with diabetes and healthcare systems (<a href="./references#CD015385-bbs2-0091" title="BeranD , YudkinJS . Diabetes care in sub-Saharan Africa. Lancet2006;368(9548):1689-95. [DOI: 10.1016/S0140-6736(06)69704-3]">Beran 2006</a>; <a href="./references#CD015385-bbs2-0092" title="BeranD , EwenM , LaingR . Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinology2016;4(3):275-85. [DOI: 10.1016/S2213-8587(15)00521-5]">Beran 2016</a>). For people with T1DM, the goal of insulin therapy is to provide insulin that mimics physiological insulin secretion in order to achieve near‐normal glycaemic levels. Insulin is most commonly administered by subcutaneous injection and is usually applied through insulin syringes, insulin pens or insulin pumps. Since the early 1920s, people with diabetes were treated with insulin, which was purified from bovine or porcine pancreas (animal insulin). Later, recombinant human insulin utilising recombinant DNA technology (<a href="./references#CD015385-bbs2-0097" title="ChanceRE , FrankBH . Research, development, production, and safety of biosynthetic human insulin. Diabetes Care1993;16(Suppl 3):133-42. [DOI: 10.2337/diacare.16.3.133]">Chance 1993</a>), and insulin analogues (insulin‐like molecules, engineered on the basis of the molecular structure of human insulin by changing amino acid sequences and physiochemical properties) were marketed (<a href="./references#CD015385-bbs2-0109" title="FullertonB , SiebenhoferA , JeitlerK , HorvathK , SemlitschT , BergholdA , et al. Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews2018, Issue 12. Art. No: CD013228. [DOI: 10.1002/14651858.CD013228]">Fullerton 2018</a>; <a href="./references#CD015385-bbs2-0115" title="HemmingsenB , MetzendorfMI , RichterB . (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. Cochrane Database of Systematic Reviews2021, Issue 3. Art. No: CD013498. [DOI: 10.1002/14651858.CD013498.pub2]">Hemmingsen 2021</a>; <a href="./references#CD015385-bbs2-0139" title="SemlitschT , EnglerJ , SiebenhoferA , JeitlerK , BergholdA , HorvathK . (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews2020, Issue 11. Art. No: CD005613. [DOI: 10.1002/14651858.CD005613.pub4]">Semlitsch 2020</a>). </p> <p>Early data indicated a loss of insulin potency depending on storage temperatures (<a href="./references#CD015385-bbs2-0093" title="BrangeJ . Galenics of Insulin. Heidelberg: Springer-Verlag, 1987.">Brange 1987</a>). The stability of human insulin depends upon a number of environmental factors (e.g. purity, pH, humidity, changes in the primary structure of the insulin molecule, added substances for enhancing or prolonging insulin absorption) and is thought to be especially susceptible to temperature and sunlight exposure (<a href="./references#CD015385-bbs2-0133" title="PingelM , VolundA . Stability of insulin preparations. Diabetes1972;21(7):805-13. [DOI: 10.2337/diab.21.7.805]">Pingel 1972</a>; <a href="./references#CD015385-bbs2-0143" title="StorvickWO , HenryHJ . Effect of storage temperature on stability of commercial insulin preparations. Diabetes1968;17(8):499-502. [DOI: 10.2337/diab.17.8.499]">Storvick 1968</a>; <a href="./references#CD015385-bbs2-0147" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9.">Vimalavathini 2009</a>). These factors may become more important because of increasingly hot weather conditions and extreme heat caused by the climate crisis (<a href="./references#CD015385-bbs2-0088" title="AtwoliL , BaquiAH , BenfieldT , BosurgiR , GodleeF , HancocksS , et al. Call for emergency action to limit global temperature Increases, restore biodiversity, and protect health. New England Journal of Medicine2021;385(12):1134-7. [DOI: 10.1056/NEJMe2113200]">Atwoli 2021</a>; <a href="./references#CD015385-bbs2-0103" title="EbiKL , CaponA , BerryP , BroderickC , deDearR , HavenithG , et al. Hot weather and heat extremes: health risks. Lancet2021;398(10301):698-708. [DOI: 10.1016/S0140-6736(21)01208-3]">Ebi 2021</a>; <a href="./references#CD015385-bbs2-0135" title="Quijal-ZamoranoM , Martinez-SolanasE , AchebakH , PetrovaD , RobineJM , HerrmannFR , et al. Seasonality reversal of temperature attributable mortality projections due to previously unobserved extreme heat in Europe. Lancet Planet Health2021;5(9):e573. [DOI: 10.1016/S2542-5196(21)00211-4]">Quijal‐Zamorano 2021</a>). Temperature affects not only diabetes control (<a href="./references#CD015385-bbs2-0149" title="WestphalSA , ChildsRD , SeifertKM , BoyleME , FowkeM , IniguezP , et al. Managing diabetes in the heat: potential issues and concerns. Endocrine Practice2010;16(3):506-11. [DOI: 10.4158/EP09344.RA]">Westphal 2010</a>), but also the pharmaceutical quality of various drugs, especially of protein and peptide‐based compounds such as insulin or monoclonal antibodies used to treat various inflammatory diseases. The potency of insulin is measured in units per millilitre (U/mL), indicating the blood glucose‐lowering activity of an insulin formulation per volume. High‐performance liquid chromatography (HPLC) is the gold standard for insulin concentration and insulin stability assessment (<a href="./references#CD015385-bbs2-0105" title='FaridNA , AtkinsLM , BeckerGW , DinnerA , HeineyRE , MinerDJ , et al. Liquid chromatographic control of the identity, purity and "potency" of biomolecules used as drugs. Journal of Pharmaceutical and Biomedical Analysis1989;7(2):185-8. [DOI: 10.1016/0731-7085(89)80082-2]'>Farid 1989</a>; <a href="./references#CD015385-bbs2-0106" title="FisherBV , SmithD . HPLC as a replacement for the animal response assays for insulin. Journal of Pharmaceutical and Biomedical Analysis1986;4(3):377-87. [DOI: 10.1016/0731-7085(86)80059-0]">Fisher 1986</a>). HPLC quantification of the chemical potency of insulin is correlated with its biological activity. Traditionally, an in vivo rabbit biopotency assay was used to monitor blood glucose over time (<a href="./references#CD015385-bbs2-0105" title='FaridNA , AtkinsLM , BeckerGW , DinnerA , HeineyRE , MinerDJ , et al. Liquid chromatographic control of the identity, purity and "potency" of biomolecules used as drugs. Journal of Pharmaceutical and Biomedical Analysis1989;7(2):185-8. [DOI: 10.1016/0731-7085(89)80082-2]'>Farid 1989</a>; <a href="./references#CD015385-bbs2-0106" title="FisherBV , SmithD . HPLC as a replacement for the animal response assays for insulin. Journal of Pharmaceutical and Biomedical Analysis1986;4(3):377-87. [DOI: 10.1016/0731-7085(86)80059-0]">Fisher 1986</a>; <a href="./references#CD015385-bbs2-0141" title="Smith HW Jr, AtkinsLM , BinkleyDA , RichardsonWG , MinerDJ . A universal HPLC determination of insulin potency. Journal of Liquid Chromatography1985;8(3):419-39.">Smith 1985</a>). However, the measured insulin potency might differ from the actual biological potency of insulin (<a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>; <a href="./references#CD015385-bbs2-0099" title="DelbeckS , KrolinskiA , DederichY , StoppelkampS , HeiseHM . A novel approach for the assessment of insulin potency by glycemic monitoring of an insulin-dependent human cell line. Journal of Diabetes Science and Technology2020;14(3):691-2. [DOI: 10.1177/1932296819895541]">Delbeck 2020a</a>; <a href="./references#CD015385-bbs2-0100" title="DelbeckS , HeiseHM . FT-IR versus EC-QCL spectroscopy for biopharmaceutical quality assessment with focus on insulin-total protein assay and secondary structure analysis using attenuated total reflection. Analytical and Bioanalytical Chemistry2020;412(19):4647-58. [DOI: 10.1007/s00216-020-02718-1]">Delbeck 2020b</a>). Insulin potency may be impacted by high or low ambient temperature, sunlight and usage beyond the expiration date, as well as exceeding the recommended usage time once opened or in use. For insulin pumps worn close to the body, the temperature in the reservoir is even higher than room temperature, and constant movements during daily activities may increase fibril formation in the insulin reservoir (<a href="./references#CD015385-bbs2-0116" title="HerrJK , KeithS , KlugR , PettisRJ . Characterizing normal-use temperature conditions of pumped insulin. Journal of Diabetes Science and Technology2014;8(4):850-4. [DOI: 10.1177/1932296814532327]">Herr 2014</a>; <a href="./references#CD015385-bbs2-0134" title="PryceR . Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight. BMJ2009;338:a2218. [DOI: 10.1136/bmj.a2218]">Pryce 2009</a>). </p> <p>In order to prevent self‐aggregation during transport and storage, zinc ions and phenolic conservative agents are added to insulin formulations to stabilise insulin molecules as hexameric complexes (<a href="./references#CD015385-bbs2-0094" title="BrangeJ , AndersenL , LaursenED , MeynG , RasmussenE . Toward understanding insulin fibrillation. Journal of Pharmaceutical Sciences1997;86(5):517-25. [DOI: 10.1021/js960297s]">Brange 1997</a>; <a href="./references#CD015385-bbs2-0119" title="HuusK , HavelundS , OlsenHB , vande WeertM , FrokjaerS . Thermal dissociation and unfolding of insulin. Biochemistry2005;44(33):11171-7. [DOI: 10.1021/bi0507940]">Huus 2005</a>; <a href="./references#CD015385-bbs2-0120" title="HuusK , HavelundS , OlsenHB , vande WeertM , FrokjaerS . Chemical and thermal stability of insulin: effects of zinc and ligand binding to the insulin zinc-hexamer. Pharmaceutical Research2006;23(11):2611-20. [DOI: 10.1007/s11095-006-9098-y]">Huus 2006</a>). Agitation or heating may cause the hexamers to dissociate and release monomers which are susceptible to forming fibrils (<a href="./references#CD015385-bbs2-0086" title="AhmadA , MillettIS , DoniachS , UverskyVN , FinkAL . Partially folded intermediates in insulin fibrillation. Biochemistry2003;42(39):11404-16. [DOI: 10.1016/j.actbio.2013.03.002]">Ahmad 2003</a>; <a href="./references#CD015385-bbs2-0124" title="KurouskiD , WashingtonJ , OzbilM , PrabhakarR , ShekhtmanA , LednevIK . Disulfide bridges remain intact while native insulin converts into amyloid fibrils. PLOS One2012;7(6):e36989. [DOI: 10.1371/journal.pone.0036989]">Kurouski 2012</a>). Formation of these insulin polymers is reported to occur up to 10 times faster at 37 °C compared to 25 °C (<a href="./references#CD015385-bbs2-0148" title="WeissM . Design of ultra-stable insulin analogues for the developing world. Journal of Health Specialities2013;1(2):59-70.">Weiss 2013</a>). Amyloid fibrils may also exhibit immunogenic capabilities (<a href="./references#CD015385-bbs2-0094" title="BrangeJ , AndersenL , LaursenED , MeynG , RasmussenE . Toward understanding insulin fibrillation. Journal of Pharmaceutical Sciences1997;86(5):517-25. [DOI: 10.1021/js960297s]">Brange 1997</a>; <a href="./references#CD015385-bbs2-0126" title="MoriW , KanekoN , NakanishiA , ZakoT , MasumotoJ . Insulin amyloid fibrils interact directly with the NLRP3, resulting in inflammasome activation and pyroptotic cell death. International Journal of Immunopathology and Pharmacology2021;35:1-7. [DOI: 10.1177/20587384211038357]">Mori 2021</a>). Insulin fibrillation by means of aggregation of insulin molecules also adversely impacts potency (<a href="./references#CD015385-bbs2-0113" title="GroenningM , FrokjaerS , VestergaardB . Formation mechanism of insulin fibrils and structural aspects of the insulin fibrillation process. Current Protein &amp; Peptide Science2009;10(5):509-28. [DOI: 10.2174/138920309789352038]">Groenning 2009</a>). If insulin within fibrils is injected subcutaneously, bioavailability is reduced because stable bonds of insulin molecules within fibrils provide fewer insulin monomers available for resorption (<a href="./references#CD015385-bbs2-0101" title="DerewendaU , DerewendaZ , DodsonGG , HubbardRE , KorberF . Molecular structure of insulin: the insulin monomer and its assembly. British Medical Bulletin1989;45(1):4-18. [DOI: 10.1093/oxfordjournals.bmb.a072320]">Derewenda 1989</a>). Fibrils may be visible in vials with the naked eye but are difficult to detect in pens or pump reservoirs. If the temperature rises, insulin degradation increases, and the combination of agitation and heat further accelerates the formation of agglomerates. Therefore, the advice is to discard insulin formations which appear visually modified (<a href="./references#CD015385-bbs2-0140" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>). However, thermal denaturation is a complex process, correlated with both time and temperature, and it may be partially reversible (<a href="./references#CD015385-bbs2-0119" title="HuusK , HavelundS , OlsenHB , vande WeertM , FrokjaerS . Thermal dissociation and unfolding of insulin. Biochemistry2005;44(33):11171-7. [DOI: 10.1021/bi0507940]">Huus 2005</a>). The application of high temperatures for a prolonged time usually leads to denaturation due to irreversible conformational changes in insulin and the formation of insulin fibrils (<a href="./references#CD015385-bbs2-0147" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9.">Vimalavathini 2009</a>). In contrast, fluctuating temperatures (compared to continuous heating conditions) may not cause irreversible aggregation of insulin molecules. For more information on insulin to help put data into perspective, see <a href="./appendices#CD015385-sec-0100">Appendix 1</a>. </p> <p>Recommendations by health authorities underline the fact that insulin is temperature sensitive and should be protected from heat and freezing conditions (<a href="./references#CD015385-bbs2-0085" title="American Diabetes Association. Insulin storage and syringe safety. www.diabetes.org/healthy-living/medication-treatments/insulin-other-injectables/insulin-storage-and-syringe-safety (accessed 15 October 2021).">ADA 2021</a>; <a href="./references#CD015385-bbs2-0089" title="BahendekaS , KaushikR , SwaiAB , OtienoF , BajajS , KalraS , et al. EADSG guidelines: insulin storage and optimisation of injection technique in diabetes management. Diabetes Therapy2019;10(2):341-66. [DOI: 10.1007/s13300-019-0574-x]">Bahendeka 2019</a>; <a href="./references#CD015385-bbs2-0098" title="DanneT , PhillipM , BuckinghamBA , Jarosz-ChobotP , SabooB , UrakamiT , et al. ISPAD clinical practice consensus guidelines 2018: insulin treatment in children and adolescents with diabetes. Pediatric Diabetes2018;19(Suppl 27):115-35. [DOI: 10.1111/pedi.12718]">Danne 2018</a>). The American Diabetes Association (ADA) published the following advice on its website (<a href="./references#CD015385-bbs2-0085" title="American Diabetes Association. Insulin storage and syringe safety. www.diabetes.org/healthy-living/medication-treatments/insulin-other-injectables/insulin-storage-and-syringe-safety (accessed 15 October 2021).">ADA 2021</a>).<br/>"Although manufacturers recommend storing your insulin in the refrigerator, injecting cold insulin can sometimes make the injection more painful. To avoid this, many providers suggest storing the bottle of insulin you are using at room temperature. Insulin kept at room temperature will last approximately one month. Remember though, if you buy more than one bottle at a time to save money, store the extra bottles in the refrigerator. Then, take out the bottle ahead of time so it is ready for your next injection. Here are some other tips for storing insulin. </p> <p> <ul id="CD015385-list-0001"> <li> <p>Do not store your insulin near extreme heat or extreme cold.</p> </li> <li> <p>Never store insulin in the freezer, in direct sunlight, or in the glove compartment of a car. </p> </li> <li> <p>Check the expiration date before using, and don't use any insulin beyond its expiration date. </p> </li> <li> <p>Examine the bottle closely to make sure the insulin looks normal before you draw the insulin into the syringe." </p> </li> </ul> </p> <p>Manufacturers' specifications recommend keeping insulin away from sunlight, not freezing it, and storing it in a refrigerator or at 'room temperature', usually not exceeding 25 °C or 30 °C (<a href="./references#CD015385-bbs2-0125" title="Humulin R – insulin human injection, solution. uspl.lilly.com/humulinru100/humulinru100.html#ug0 (assessed 25 June 2023).">Lilly 2023</a>; <a href="./references#CD015385-bbs2-0127" title="Insulatard: EPAR – product information. www.ema.europa.eu/documents/product-information/insulatard-epar-product-information_en.pdf (assessed 29 June 2023).">Novo Nordisk 2020a</a>; <a href="./references#CD015385-bbs2-0128" title="Actrapid: EPAR – product information. www.ema.europa.eu/documents/product-information/actrapid-epar-product-information_en.pdf (assessed 29 June 2023).">Novo Nordisk 2020b</a>). Nevertheless, room temperature may be defined differently in various parts of the world. Intact vials of insulin should be stored at low temperatures (i.e. between 2 °C and 8 °C), requiring affordable and reliable refrigeration. However, refrigeration may not be available or possible in some parts of the world (<a href="./references#CD015385-bbs2-0129" title="OgleGD , AbdullahM , MasonD , JanuszewskiAS , BesançonS . Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques. Diabetic Medicine2016;33(11):1544-53. [DOI: 10.1111/dme.13194]">Ogle 2016</a>). Moreover, unlike pharmaceutical refrigerators, household refrigeration may be unreliable, and temperatures can drop below the freezing point (<a href="./references#CD015385-bbs2-0114" title="HeinemannL , BrauneK , CarterA , ZayaniA , KrämerLA . Insulin storage: a critical reappraisal. Journal of Diabetes Science and Technology2021;15(1):147-59. [DOI: 10.1177/1932296819900258]">Heinemann 2021</a>). Once opened, a vial or cartridge can be stored at ambient temperature and used for approximately four to six weeks (<a href="./references#CD015385-bbs2-0125" title="Humulin R – insulin human injection, solution. uspl.lilly.com/humulinru100/humulinru100.html#ug0 (assessed 25 June 2023).">Lilly 2023</a>; <a href="./references#CD015385-bbs2-0127" title="Insulatard: EPAR – product information. www.ema.europa.eu/documents/product-information/insulatard-epar-product-information_en.pdf (assessed 29 June 2023).">Novo Nordisk 2020a</a>; <a href="./references#CD015385-bbs2-0128" title="Actrapid: EPAR – product information. www.ema.europa.eu/documents/product-information/actrapid-epar-product-information_en.pdf (assessed 29 June 2023).">Novo Nordisk 2020b</a>). The contents of the vial or cartridge are technically no longer sterile, and it is recommended to use the insulin in as short a time as possible to minimise concerns about potential microbiological contamination once the container has been opened or punctured. However, recommendations with regard to advised usage time once open and maximum temperature in‐use differ with type of insulin, brand, insulin concentrations and carrier (vial, pen, cartridge, pump) (table 1 in <a href="./references#CD015385-bbs2-0114" title="HeinemannL , BrauneK , CarterA , ZayaniA , KrämerLA . Insulin storage: a critical reappraisal. Journal of Diabetes Science and Technology2021;15(1):147-59. [DOI: 10.1177/1932296819900258]">Heinemann 2021</a> and table S1 in <a href="./references#CD015385-bbs2-0122" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16(2):e0245372. [DOI: 10.1371/journal.pone.0245372]">Kaufmann 2021</a>). For human insulin, the current shelf life in use may range from 10 to 45 days and the recommended maximum temperature in‐use varies between 25 °C and 37 °C. Tropical regions will often exceed these temperature thresholds and, due to the climate crisis, periods of extreme heat will occur more often in almost any part of the world. Whereas WHO (<a href="./references#CD015385-bbs2-0151" title="WHO Technical Report Series, No 961. Model guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products. www.who.int/medicines/areas/quality_safety/quality_assurance/ModelGuidanceForStorageTransportTRS961Annex9.pdf?ua=1 (accessed 15 October 2021).">WHO 2011</a>) and regulatory bodies provide guidance on how to handle the professional insulin cold chain, there does not seem to be a consensus on the issue of temperature and storage conditions of insulin at patients' level. Unclear or conflicting information about optimal insulin storage may not only put patients' health at risk, but may also lead to the possibility that unused insulin is unnecessarily discarded (<a href="./references#CD015385-bbs2-0108" title="FloodTM . In response: how long should insulin be used once a vial is opened?Endocrine Practice2015;21(2):213.">Flood 2015</a>; <a href="./references#CD015385-bbs2-0111" title="GrajowerMM , FraserCG , HolcombeJH , DaughertyML , HarrisWC , De-FelippisMR , et al. How long should insulin be used once a vial is started?Diabetes Care2003;26(9):2665-9. [DOI: 10.2337/diacare.26.9.2665]">Grajower 2003</a>; <a href="./references#CD015385-bbs2-0112" title="GrajowerM . How long can a vial of insulin be used after it is started: where are we 10 years later?Endocrine Practice2014;20(2):188-90. [DOI: 10.4158/EP13427.CO]">Grajower 2014</a>). </p> <p>For this review, optimal cold‐chain management from manufacturing until the point of delivery to people with diabetes, and adequate storage conditions at the professional healthcare level, are seen as a prerequisite to investigating whether it is possible for consumers to safely use insulin outside manufacturers' recommended temperature range, especially without refrigeration during the period of use in hot climate conditions. This is particularly important in tropical and low‐resource settings to remove at least one significant barrier in the treatment of people with diabetes aside from the major health equity issues of affordability and availability of human insulin (<a href="./references#CD015385-bbs2-0122" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16(2):e0245372. [DOI: 10.1371/journal.pone.0245372]">Kaufmann 2021</a>). </p> <section id="CD015385-sec-0010"> <h3 class="title" id="CD015385-sec-0010">Why it is important to do this review</h3> <p>According to Naby Baldé, Vice‐President of the IDF, "The majority of families in low‐ and middle‐income countries do not have refrigeration facilities in their homes, or electric power and, therefore, diverse methods of safely storing insulin should be devised" (<a href="./references#CD015385-bbs2-0102" title="DeviS . Cold comfort: getting insulin to those who need it. Lancet2021;398(10313):1791.">Devi 2021</a>). Around 770 million people in LMICs do not have access to electricity (<a href="./references#CD015385-bbs2-0095" title="BurkiT . Hot topics on insulin access: the issue of thermostability. Lancet. Diabetes &amp; Endocrinology2022;10(6):389-90. [DOI: 10.1016/ S2213-8587(22)00140-1]">Burki 2022</a>; <a href="./references#CD015385-bbs2-0132" title="PandeAR , ThakurAK . Perceptions of alternative methods of insulin storage: an ethical dilemma. Lancet. Diabetes &amp; Endocrinology2022;10(8):558.">Pande 2022</a>). Therefore, we believe that this Cochrane Review provides useful information for the global diabetes community residing in tropical regions and living in challenging settings such as war‐torn and natural disaster‐stricken areas or experiencing climate crisis‐related periods of extreme heat. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD015385-sec-0011" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD015385-sec-0011"></div> <p>To analyse the effects of storing human insulin above or below the manufacturers' recommended insulin temperature storage range or advised usage time, or both, after dispensing human insulin to people with diabetes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD015385-sec-0012" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD015385-sec-0012"></div> <section id="CD015385-sec-0013"> <h3 class="title" id="CD015385-sec-0013">Inclusion and exclusion criteria</h3> <p>With regard to the objectives, we established the following 'Population, Intervention, Comparator, Outcome, Timing' (PICOT) table, as follows. </p> <p> <div class="table" id="CD015385-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Item</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Definition</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>P</b>opulation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Clinical studies: people with type 1 or type 2 diabetes mellitus treated with human insulin </p> <p>2. Laboratory studies investigating insulin thermostability</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>I</b>ntervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Storage of human insulin above or below manufacturers' recommended temperature storage range or advised usage time, or both </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>C</b>omparator </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Storage of human insulin according to manufacturers' recommended temperature storage range or advised usage time, or both </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>O</b>utcome </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. and 2. Potency and bioactivity parameters (e.g. measured by HPLC, bioassay, assessment of insulin monomer structure, insulin efficiency, structural physical damage, physical damage visible to the naked eye, antimicrobial activity) </p> <p>1. Clinical parameters (e.g. HbA1c, blood sugar, hypoglycaemic episodes, diabetic ketoacidosis, adverse events including potential additive effects of temperatures and recommended storage periods, health‐related quality of life) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>T</b>iming </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Temperature studies: any time of exposure</p> <p>Usage time studies: above manufacturers' recommended usage time for the analysed human insulin formulation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>HbA1c: glycosylated haemoglobin A1c; HPLC: high‐performance liquid chromatography.</p> </td> </tr> </tbody> </table> </div> </p> <section id="CD015385-sec-0014"> <h4 class="title">Types of studies</h4> <p>We included any clinical study fulfilling the above‐mentioned PICOT criteria. For this review, we were especially interested in studies emulating living conditions of people with diabetes, mimicking the daily use of human insulin. We also included laboratory studies investigating the storage of human insulin above or below manufacturers' recommended temperature storage range or advised usage time, or both. </p> </section> <section id="CD015385-sec-0015"> <h4 class="title">Diagnostic criteria for diabetes mellitus</h4> <p>In order to be consistent with changes in the classification of and diagnostic criteria for diabetes mellitus over the years, the diagnosis should have been established using the standard criteria valid at the time of the study commencing (e.g. <a href="./references#CD015385-bbs2-0083" title="Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care2003;26(Suppl 1):S5-20.">ADA 2003</a>; <a href="./references#CD015385-bbs2-0084" title="American Diabetes Association. Standards of medical care in diabetes – 2017. Diabetes Care2017;40(Suppl 1):S11-33.">ADA 2017</a>; <a href="./references#CD015385-bbs2-0150" title="World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. In: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva (Switzerland): World Health Organization, 1999:1-59.">WHO 1999</a>). Ideally, the diagnostic criteria should have been described. We used the study authors' definition of diabetes mellitus if necessary. </p> </section> <section id="CD015385-sec-0016"> <h4 class="title">Specific exclusion criteria</h4> <p>We excluded the following studies.</p> <p> <ul id="CD015385-list-0002"> <li> <p>Studies investigating animal insulin.</p> </li> <li> <p>Studies investigating insulin analogues.</p> </li> <li> <p>Studies investigating the immediate effects of ambient temperature on people with diabetes (i.e. no focus on storage conditions of human insulin). </p> </li> <li> <p>In‐vitro studies on cells or receptors.</p> </li> <li> <p>Case reports or case series.</p> </li> </ul> </p> </section> </section> <section id="CD015385-sec-0017"> <h3 class="title" id="CD015385-sec-0017">Search methods for identification of studies</h3> <section id="CD015385-sec-0018"> <h4 class="title">Electronic searches</h4> <p>One review author (MIM) developed the search strategies using analytical text‐mining of 24 relevant publications already known to a second review author (BR), using the tools PubReMiner (<a href="https://hgserver2.amc.nl/cgi-bin/miner/miner2.cgi" target="_blank">hgserver2.amc.nl/cgi-bin/miner/miner2.cgi</a>) and Yale MeSH Analyzer (<a href="https://mesh.med.yale.edu" target="_blank">mesh.med.yale.edu</a>). </p> <p>We searched the following sources from inception of each database to 12 July 2023 and placed no restrictions on the language of publication: </p> <p> <ul id="CD015385-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Register of Studies Online (CRSO); </p> </li> <li> <p>MEDLINE (Ovid MEDLINE(R) ALL 1946 to 22 July 2023);</p> </li> <li> <p>CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature);</p> </li> <li> <p>Science Citation Index Expanded (Web of Science);</p> </li> <li> <p>WHO Global Index Medicus (<a href="http://www.globalindexmedicus.net/" target="_blank">www.globalindexmedicus.net</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>); </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">www.who.int/trialsearch</a>). </p> </li> </ul> </p> <p>For detailed search strategies, see <a href="./appendices#CD015385-sec-0101">Appendix 2</a>. We continuously applied an email alert service for MEDLINE via OvidSP to identify newly published studies using the search strategy detailed in <a href="./appendices#CD015385-sec-0101">Appendix 2</a>. </p> </section> <section id="CD015385-sec-0019"> <h4 class="title">Searching other resources</h4> <p>We contacted the three leading insulin‐producing pharmaceutical companies (Eli Lilly and Company, Novo Nordisk, Sanofi) and two pharmaceutical companies producing biosimilar insulin (BIOTON, Gan and Lee Pharmaceuticals) to obtain published and unpublished data on insulin thermostability. We attempted to identify other potentially eligible studies or ancillary publications by searching the reference lists of included studies, systematic reviews and meta‐analyses. We also contacted the authors of included studies to obtain additional information on the studies and establish whether we may have missed further studies. </p> </section> </section> <section id="CD015385-sec-0020"> <h3 class="title" id="CD015385-sec-0020">Data collection and analysis</h3> <section id="CD015385-sec-0021"> <h4 class="title">Selection of studies</h4> <p>Two review authors (BR, BB) independently screened the abstract, title, or both, of every record retrieved by the electronic searches. We obtained the full text of all potentially relevant records. We planned to resolve disagreements through consensus or by recourse to a third review author (MIM). If we could not resolve a disagreement, we planned to categorise the study as 'awaiting classification' and would have contacted the study authors for clarification. We presented an adapted PRISMA flow diagram to show the process of study selection (<a href="./references#CD015385-bbs2-0131" title="PageMJ , McKenzieJE , BossuytPM , BoutronI , HoffmannTC , MulrowCD , et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021;372:n71. [DOI: 10.1136/bmj.n71]">Page 2021</a>). We listed all articles excluded after full‐text assessment in the <a href="./references#CD015385-sec-0112" title="">Characteristics of excluded studies</a> table and provided the reasons for exclusion. </p> </section> <section id="CD015385-sec-0022"> <h4 class="title">Data extraction and management</h4> <p>For studies that fulfilled our inclusion criteria, one review author (BR) extracted the type of experimental study, study characteristics, stated aim of the study, type and brand of human insulin, use of concomitant oral antidiabetic agents, data on cold chain management, temperature (constant, oscillating or both), light exposure and usage time, container use (unopened, open, in‐use), container type (vial, cartridge, prefilled pens), sterility, injection device (syringe, pen, pump), storage conditions, potency/bioactivity parameters and clinical outcomes. </p> <p>Another review author (BB) checked these data extractions, and we planned to resolve any disagreements by discussion or, if required, by consultation with a third review author (MIM). We established our own context‐specific data extraction sheets after piloting data extraction for five studies. We planned to store all extracted data and risk of bias evaluations (see below) online in an open repository (<a href="https://zenodo.org/" target="_blank">Zenodo.org</a>). </p> <p>We emailed all authors of included studies to enquire whether they would be willing to answer questions regarding their studies. We presented the results of this survey in an appendix. Thereafter, we sought relevant missing information on the study from the primary study author(s), if required. </p> <p>We planned to provide information for potentially relevant ongoing trials in the Characteristics of ongoing studies table. </p> </section> <section id="CD015385-sec-0023"> <h4 class="title">Dealing with duplicate and companion publications</h4> <p>In the event of duplicate publications, companion documents or multiple reports of a primary study, we maximised the information yield by collating all available data, and we used the most complete data set aggregated across all known publications. We listed duplicate publications, companion documents, multiple reports of a primary study, and trial documents of included trials (such as trial registry information) as secondary references under the study identifier of the included study. Furthermore, we listed duplicate publications, companion documents, multiple reports of a study and trial documents of excluded trials (such as trial registry information) as secondary references under the study identifier of the excluded study. </p> </section> <section id="CD015385-sec-0024"> <h4 class="title">Data from clinical trial registers</h4> <p>If data from included trials were available as study results in clinical trial registers, such as <a href="http://clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a> or similar sources, we planned to make full use of this information and extract the data. If there was also a full publication of the study, we collated and critically appraised all available data. If an included study was marked as completed in a clinical trial register but there was no additional information (study results or publication, or both) available, we planned to add this study to the Characteristics of studies awaiting classification table. </p> </section> <section id="CD015385-sec-0025"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (BR, BB) planned to independently assess the risk of bias for each included study. We planned to resolve disagreements by consensus or by consulting a third review author (MIM). If adequate information was not available from the study publications, study protocols or other sources, we planned to contact the study authors to request missing data on items relating to the risk of bias. </p> <p>For randomised controlled trials (RCTs), we planned to use the Cochrane RoB 2 tool (<a href="./references#CD015385-bbs2-0107" title="FlemyngE , MooreTH , BoutronI , HigginsJP , HróbjartssonA , NejstgaardCH , et al. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane. BMJ Evidence-Based Medicine2023;28:260-6. [DOI: 10.1136/bmjebm-2022-112102]">Flemyng 2023</a>; <a href="./references#CD015385-bbs2-0117" title="HigginsJP , SavovićJ , PageMJ , ElbersRG , SterneJA . Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022a</a>). For non‐randomised clinical studies, we planned to use the Cochrane risk of bias in non‐randomised studies of interventions tool, ROBINS‐I (<a href="./references#CD015385-bbs2-0142" title="SterneJA , HernanMA , ReevesBC , SavovicJ , BerkmanND , ViswanathanM , et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:i4919. [DOI: 10.1136/bmj.i4919]">Sterne 2016</a>). For all other types of included studies, we planned to address risk of bias in a meaningful and transparent way, if possible, using appropriate instruments described in the literature. </p> </section> <section id="CD015385-sec-0026"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to obtain missing data from the authors of included studies.</p> </section> <section id="CD015385-sec-0027"> <h4 class="title">Data synthesis</h4> <p>We did not expect data suitable for meta‐analysis. If possible, we planned to perform statistical analyses according to the statistical guidelines presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015385-bbs2-0118" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022b</a>). In case statistical analyses were not possible or meaningful, we planned to present data in a highly structured tabulated format which we wanted to store online in an open repository (<a href="https://zenodo.org/" target="_blank">Zenodo.org</a>). </p> </section> <section id="CD015385-sec-0028"> <h4 class="title">Subgroup analysis</h4> <p>We expected the following characteristics to introduce heterogeneity, and we planned to investigate the following subgroups, if feasible. </p> <p> <ul id="CD015385-list-0004"> <li> <p>Insulin type</p> </li> <li> <p>Storage temperature (depending on data)</p> </li> <li> <p>Usage time (depending on data)</p> </li> <li> <p>Injection device</p> </li> </ul> </p> </section> <section id="CD015385-sec-0029"> <h4 class="title">Sensitivity analysis</h4> <p>Should meta‐analysis have been possible, we planned to explore the influence of important factors on effect sizes, by performing sensitivity analyses in which we restricted the analyses to the following. </p> <p> <ul id="CD015385-list-0005"> <li> <p>Published studies</p> </li> <li> <p>Studies with low risk of bias</p> </li> <li> <p>Large studies, to establish the extent to which they dominate the results</p> </li> </ul> </p> </section> </section> <section id="CD015385-sec-0030"> <h3 class="title" id="CD015385-sec-0030">Certainty of the evidence</h3> <p>For clinical studies, we planned to present the overall certainty of the evidence for each outcome specified below, according to the GRADE approach, which takes into account issues related to internal validity (risk of bias, inconsistency, imprecision, publication bias) and external validity (such as directness of results). Two review authors (BR, BB) planned to independently assess the certainty of the evidence for each outcome. We wanted to resolve any differences in assessment by discussion or by consultation with a third review author (MIM). We planned to use <a href="./references#CD015385-bbs2-0110" title="GRADEpro GDT. Version accessed 29 June 2023. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a> software and wanted to present evidence profile tables as an appendix. </p> <p>If meta‐analysis was not possible, we presented the results in a narrative format in the summary of findings tables. If possible, we justified all decisions to downgrade the certainty of the evidence using footnotes, and we made comments to aid the reader's understanding of the Cochrane Review when necessary. </p> <section id="CD015385-sec-0031"> <h4 class="title">Summary of findings table</h4> <p>We presented a summary of the evidence in summary of findings tables. For clinical studies, we provided key information about the best estimate of the magnitude of effect, in relative terms and as absolute differences for each relevant comparison of alternative management strategies; the numbers of participants and studies addressing each important outcome; and a rating of overall confidence in effect estimates for each outcome. We created summary of findings tables using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015385-bbs2-0138" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Schünemann 2022</a>). </p> <p>According to our PICOT setting, interventions presented in the summary of findings tables were planned to be the storage of human insulin above or below manufacturers' recommended temperature storage range or advised usage time, or both. The comparators were the storage of human insulin according to manufacturers' recommended temperature storage range or advised usage time, or both. </p> <p>We wanted to evaluate the following outcomes reported in clinical studies, listed according to priority. </p> <p> <ul id="CD015385-list-0006"> <li> <p>Potency/bioactivity parameters of human insulin</p> </li> <li> <p>Diabetic ketoacidosis</p> </li> <li> <p>Hypoglycaemic episodes</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Health‐related quality of life</p> </li> <li> <p>Glycosylated haemoglobin A1c (HbA1c)</p> </li> <li> <p>Fasting blood/plasma glucose</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD015385-sec-0032" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD015385-sec-0032"></div> <section id="CD015385-sec-0033"> <h3 class="title" id="CD015385-sec-0033">Results of the search</h3> <p>After removal of duplicates, our search identified 7051 records (<a href="#CD015385-fig-0001">Figure 1</a>). We excluded most of the references on the basis of their titles and abstracts because they clearly did not meet the inclusion criteria. We evaluated 91 full‐text articles. Of these, we excluded 69 articles. The main reasons for exclusion were studies investigated insulin other than human insulin, commentaries/viewpoints providing no data and studies on storage conditions without insulin. We did not identify any ongoing trials. Finally, we included 17 studies (22 records). We supplemented our searches by screening reference lists of all eligible articles. </p> <div class="figure" id="CD015385-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD015385-fig-0001" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We contacted all study authors in case we required further information or clarification (<a href="./appendices#CD015385-sec-0102">Appendix 3</a>). Six authors replied (<a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>; <a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>; <a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>; <a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a>; <a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>), and three authors made additional data available (<a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>; <a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>). </p> <p>Building on the advice from the WHO, we contacted five manufacturers of human insulin (BIOTON and Gan and Lee Pharmaceuticals (both biosimilar manufacturers), Eli Lilly and Company, Novo Nordisk, Sanofi). We requested specific data on human insulin when tested above or below the manufacturers' recommended insulin temperature storage range or advised usage time, or both and provided an Excel template detailing the sort of container, batch number, storage condition, time points of storage, investigated components, results including result unit and reference range. We received data with varying degrees of detail from BIOTON, Eli Lilly and Company, Novo Nordisk and Sanofi. </p> </section> <section id="CD015385-sec-0034"> <h3 class="title" id="CD015385-sec-0034">Baseline characteristics of included studies</h3> <p>For details on baseline characteristics of the included studies, see <a href="#CD015385-tbl-0004">Table 1</a>; <a href="#CD015385-tbl-0005">Table 2</a>. </p> <div class="table" id="CD015385-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics (I)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Stated aim of study (quotes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Country</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Type and brand of human insulin</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pilot clinical study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The purpose of our study was to demonstrate the possible effect on the bioactivity of insulin, following storage in a zeer, a semiporous clay pot containing water, in desert conditions." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saudi Arabia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neutral human insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In an attempt to challenge the findings of Carter and Heinemann, we set out to develop a high‐throughput (1 min/sample) high‐resolution MS method to quantify insulin content and stability in vials." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> <p>Insulin aspart</p> <p>Faster‐acting insulin aspart</p> <p>Insulin glargine</p> <p>Insulin lispro</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Infrared (IR) spectroscopy has been successfully utilized for secondary structure analysis in cases of protein misfolding and fibril formation." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin detemir</p> <p>Insulin aspart</p> <p>NPH insulin human</p> <p>Insulin lispro</p> <p>Insulin lispro NPH insulin</p> <p>Insulin glargine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The purpose of this study was to evaluate the immunologic and radioreceptor degradation of insulin storage in commercial plastic syringes." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin<br/>Porcine insulin<br/>Lente iletin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"First, how much insulin transformation had occurred in vials by the time patients had finished with them? Next what was the importance of temperature, light, agitation, and regular withdrawal of insulin on the rates of appearance of three groups of ITP (insulin transformation product)? Finally, how did rates of transformation in vials issued to patients compare with vials from the same batch stored in various laboratory environments?" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> <p>Beef insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this work, therefore, the question addressed is whether commercially available insulin is stable under high oscillating ambient temperatures for a period of four weeks (28 days), which corresponds to the usual recommended period of use of most commercially available insulins upon opening of the vial or cartridge." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Actrapid<br/>Insulatard<br/>Mixtard 30 <br/>Novorapid <br/>Lantus Solostar<br/>Humalog KwikPen<br/>Humalog KwikPen mix 25 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The aim of this study was to evaluate the sterility of insulin and syringes when they were kept under refrigeration for up to 10 days." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Israel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin <br/>Rapid‐acting insulin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Investigates the effect of temperature on the stability of basal insulin at 28 days after opening." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thailand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NPH insulins</p> <p>Insulin analogue</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The objective of this study was to determine if U‐500 insulin is stable when stored in prefilled syringes at 4 °C for up to 28 days." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"On the background of the article by Carter and Heinemann and given the importance of insulin quality on patient outcomes, we evaluated insulin concentrations in vials from three different sources: (1) we analyzed insulin content and stability based on production batches covering 7 years of production, (2) we measured insulin content from the last three years of insulin samples returned to Novo Nordisk from patients in the United States because of concerns expressed by the patients, and (3) we reviewed data from 10 years of independent European Medicines Association (EMA) sampling and testing of products." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐acting insulin</p> <p>Intermediate‐acting insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this pilot study, we aimed to identify: (1) the potency of six 100 IU/mL insulins (vials of human soluble; Eli Lilly), human isophane (Eli Lilly), and human soluble–isophane (30:70; Novo Nordisk); and 3 mL cartridges of insulin aspart (Novo Nordisk), and two preparations of insulin glargine (Sanofi and Eli Lilly) stored unopened for 1–4 months in non‐refrigerated conditions in a real‐world setting during the summer in India, all compared with control samples of each insulin, which remained refrigerated; and (2) whether there was any difference in storage temperatures and changes in potency between samples stored within and outside clay pots. These insulins were chosen to include commonly used insulins." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin:</p> <p>Humulin R<br/>Humulin N<br/>Mixtard 30/70 </p> <p>Analogue insulin:<br/>Novorapid<br/>Lantus/Basaglar </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this study we investigated with High Performance Liquid Chromatography (HPLC) (reversed phase chromatography and gel‐filtration) the aggregational behaviour of pork and human soluble insulin formulations under variations of motion and temperature." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> <p>Pork insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this study, aspects of the test development have been addressed such as the test conditions, automation of physical stress testing, and results for different formulations." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin regular, NPH, biphasic (70/30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"To evaluate the stability of two long‐acting insulin formulations, Humulin 70/30 and Levemir, after 28 days." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin biphasic (70/30)</p> <p>Insulin detemir</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this work, we investigated the effects of temperature and intermittent handling on the formation of subvisible and submicrometer protein particles in commercial insulin formulations." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin H – regular H</p> <p>Human insulin N – regular N</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"This study was conducted to determine the stability of a variety of biosynthetic human insulin products, along with their preservatives, when stored in two commonly used plastic insulin syringes." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin regular, NPH, biphasic (70/30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"… we undertook this study to compare the potency of human insulin from three different manufacturers after storing at different temperatures and durations." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin regular, biphasic (30/70)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>IU: insulin unit; lab: laboratory; MS: mass spectrometric; NPH: neutral protamine Hagedorn. </p> </div> </div> <div class="table" id="CD015385-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline characteristics (II)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Injection and container device</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Temperature and storage conditions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurements</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (opened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0007"> <li> <p>Temperature: outside 38.3 °C; insulin zeer 26.6 °C; dry zeer 34.6 °C; insulin vials stored in the shade 35.3 °C; water zeer 26.7 °C; bathroom 26.4 °C; refrigerator 4 °C </p> </li> <li> <p>Storage period: 6 weeks</p> </li> <li> <p>Storage conditions: clay pot (zeer) containing water; dry zeer; insulin vials in the shade; water zeer; bathroom (air‐conditioned house); refrigerator </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Twice‐daily sampling of insulin 10 U (simulation of usage conditions)</i> </p> <p> <ul id="CD015385-list-0008"> <li> <p>Temperature readings on 12 occasions</p> </li> <li> <p>Plasma glucose measurements after intravenous injection of 0.1 U/kg bodyweight of regular insulin </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0009"> <li> <p>Temperature: 4 °C, 22 °C, 37 °C</p> </li> <li> <p>Storage period: 1–85 days</p> </li> <li> <p>Storage conditions: temperature‐controlled environments with electronic temperature monitoring (refrigerator or incubators) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0010"> <li> <p>Mass spectrometry (insulin concentration)</p> </li> <li> <p>Screening for degradation products</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0011"> <li> <p>Temperature: 0 °C, 20 °C, 37 °C</p> </li> <li> <p>Storage period: up to 10 weeks</p> </li> <li> <p>Storage conditions: climatic exposure cabinets</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0012"> <li> <p>Infrared spectroscopy in combination with attenuated total reflection technique (comparison of protein structural changes) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0013"> <li> <p>Temperature: 4 °C</p> </li> <li> <p>Storage period: 1, 3, 7 and 14 days</p> </li> <li> <p>Storage conditions: refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0014"> <li> <p>Insulin radioimmunoassay (insulin potency)</p> </li> <li> <p>Radioreceptor assay (binding to hepatic insulin receptors)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (opened, some samples)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0015"> <li> <p>Temperature: 19–24 °C (room temperature in the dark), 18–25 °C (room temperature in daylight), 8–35 °C (in direct sunlight on a window sill), 37 °C (in the dark), 4 °C (in the dark), carried in the breast pocket of a shirt </p> </li> <li> <p>Storage period: 2, 4, 6, 8, 10, 14, 18 and 26 weeks</p> </li> <li> <p>Storage conditions: under environmental conditions in the laboratory</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Twice‐daily sampling (simulation of usage conditions)</i> </p> <p> <ul id="CD015385-list-0016"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials and cartridges/pens<br/>(opened, some samples) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0017"> <li> <p>Oscillating temperatures 25–37 °C; isothermal (continuous) temperatures 31 °C and 37 °C </p> </li> <li> <p>Storage period: oscillating temperatures 4 and 12 weeks; isothermal (continuous) temperatures 1, 2, 4 and 8 weeks </p> </li> <li> <p>Storage conditions: incubators replicating temperature fluctuations in the Dagahaley refugee camp (Northern Kenya); a series of mixed insulin vials were stored at ambient temperature in Kenya for 4 weeks of use by patients and brought back to Geneva for analysis </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>For some samples, insulin was taken out daily (simulation of usage conditions with dosages of 10 IU in the morning and 12 IU in the evening)</i> </p> <p> <ul id="CD015385-list-0018"> <li> <p>Insulin potency (RP‐HPLC coupled with UV detection)</p> </li> <li> <p>Secondary structure of insulin monomers (measuring circular dichroism)</p> </li> <li> <p>Residual insulin bioactivity by measuring insulin efficiency on insulin receptor and akt kinase activation (Akt) phosphorylation in hepatic cells </p> </li> <li> <p>Visual inspection</p> </li> <li> <p>Microbial contamination (by transmission electron microscopy)</p> </li> <li> <p>Phenol and metacresol concentration</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0019"> <li> <p>Temperature: 4 °C</p> </li> <li> <p>Storage period: 10 days</p> </li> <li> <p>Storage conditions: refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0020"> <li> <p>Sterility</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges/pens (opened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0021"> <li> <p>Temperature: mean 29.7 °C (2.8 SD), range 25.5–37.1 °C; 2–8 °C; 37 °C</p> </li> <li> <p>Storage period: 28 days</p> </li> <li> <p>Storage conditions: room; refrigerator; incubator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>2 units of insulin were discarded every day (simulation of usage conditions)</i> </p> <p> <ul id="CD015385-list-0022"> <li> <p>Insulin potency (ultra HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0023"> <li> <p>Temperature: 3–5 °C</p> </li> <li> <p>Storage period: 7, 14, 21 and 28 days</p> </li> <li> <p>Storage conditions: laboratory refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0024"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0025"> <li> <p>Temperature: 5 °C, followed by 30 °C</p> </li> <li> <p>Storage period: 30 months + 6 weeks (to mimic in‐use impact); 30 months + 10 weeks (4 weeks to mimic non‐recommended handling conditions + 6 weeks to mimic in‐use impact) </p> </li> <li> <p>Storage conditions: refrigerator + unspecified ("left at 30 °C")</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0026"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0027"> <li> <p>Temperature: 26.3–28.9 °C (clay pot in shaded area)</p> </li> <li> <p>Storage period: 1, 2 and 4 months</p> </li> <li> <p>Storage conditions: clay pot, open box, laboratory refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0028"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> <li> <p><sup>1</sup>H NMR </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0029"> <li> <p>Temperature: 37 °C, ambient temperature</p> </li> <li> <p>Storage period: 72 hours</p> </li> <li> <p>Storage conditions: shaking for 72 hours (75 or 150 rotations/min)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0030"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> <li> <p>Gel‐filtration chromatography</p> </li> <li> <p>Radioimmunological activity</p> </li> <li> <p>Bacterial growth after inoculation</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges/pens (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0031"> <li> <p>Oscillating temperatures (OT) 25–37 °C; continuous temperature (CT) 37 °C (combined with periodic daily agitation by specially constructed rotation devices) </p> </li> <li> <p>Storage period: OT 7, 14, 21, 8 days; CT 2, 5, 7, 9, 11, 14, 17, 21, 24, 28 days</p> </li> <li> <p>Storage conditions: incubator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Resuspensions were conducted twice daily on a mechanical device outside the incubator unit</i> </p> <p> <ul id="CD015385-list-0032"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> <li> <p>Visual changes (optical phase‐contrast microscopy)</p> </li> <li> <p>Particle size determination</p> </li> <li> <p>Electrophoretic mobility measurements</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0033"> <li> <p>Temperature: 2–8 °C; 22–24 °C</p> </li> <li> <p>Storage period: 28, 35 and 42 days</p> </li> <li> <p>Storage conditions: refrigerator; room</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0034"> <li> <p>Insulin potency (HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0035"> <li> <p>Temperature: 4 °C, 37 °C</p> </li> <li> <p>Storage period: 35 days</p> </li> <li> <p>Storage conditions: refrigerator/incubator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein structure:</p> <p> <ul id="CD015385-list-0036"> <li> <p>Dynamic light scattering: determination of oligomeric and particulate distribution of insulin </p> </li> <li> <p>Transmission electron microscopy: morphological characterisation of insulin HMWP</p> </li> <li> <p>Thioflavin T fluorescence: formation of amyloid material</p> </li> <li> <p>Size exclusion chromatography: analysis of insulin formulations</p> </li> <li> <p>Electrospray ionisation mass spectrometry analysis in conjunction with ion mobility: formation of aggregates due to chemical degradation </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0037"> <li> <p>Temperature: 3–5 °C; 22–23 °C</p> </li> <li> <p>Storage period: 1, 3, 7, 14, 21 and 28 days</p> </li> <li> <p>Storage conditions: refrigerator; room</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0038"> <li> <p>Insulin potency (HPLC)</p> </li> <li> <p>Metacresol and phenol concentrations</p> </li> <li> <p>Sterility</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (probably unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0039"> <li> <p>Temperature: 5 °C, 32 °C, 37 °C, 25 °C, 26 °C</p> </li> <li> <p>Storage period: 7, 14 and 28 days</p> </li> <li> <p>Storage conditions: refrigerator; room temperature; room temperature in summer; air‐conditioned room; mud pot </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0040"> <li> <p>Insulin potency (HPLC)</p> </li> <li> <p>Blood glucose (rabbit test)</p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Short‐acting insulin was withdrawn for commercial reasons by the manufacturer. </p> <p><sup>1</sup>H NMR: proton nuclear magnetic resonance spectroscopy; HMWP: high molecular weight protein; HPLC: high‐performance liquid chromatography; IU: insulin unit; (RP)‐HPLC: (reverse‐phase) high‐performance liquid chromatography; SD: standard deviation; U: unit; UV: ultraviolet. </p> </div> </div> <p>Of the 17 included studies, there was only one pilot clinical study (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>), and the remaining 16 investigations were laboratory (in‐vitro) studies. Ten studies investigated storage conditions for insulin vials (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>; <a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>; <a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a>; <a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a>; <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>; <a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a>; <a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a>; <a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>; <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>). Three studies investigated storage conditions for insulin cartridges/pens (<a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>; <a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>; <a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>). Four studies investigated storage conditions for prefilled plastic syringes (<a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a>; <a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a>; <a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a>; <a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a>). </p> <p>Six studies were published in the USA; two studies each in Germany, India and Switzerland; and one study each in Brazil, Israel, Saudi Arabia, the UK and Thailand. </p> </section> <section id="CD015385-sec-0035"> <h3 class="title" id="CD015385-sec-0035">Data from study publications</h3> <p>In this review, we reported data on human insulin formulations only (for details, see <a href="./references#CD015385-sec-0111" title="">Characteristics of included studies</a> table). To put human insulin data into perspective, see <a href="./appendices#CD015385-sec-0100">Appendix 1</a>. </p> <section id="CD015385-sec-0036"> <h4 class="title">Pilot clinical study</h4> <p>For an overview of main results, see <a href="./full#CD015385-tbl-0001">summary of findings Table 1</a>. </p> <p>Eight healthy physicians (aged 25 to 60 years) participated in the study (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>). In the open section of the study, four males used 'prestorage' insulin as reference insulin. In the double‐blind section of the study, four females used refrigerated (4 °C) insulin as reference. For these participants, the reference insulin and the insulin stored in a clay pot were available at the same time and the order of use was randomised using a coin toss. Here, both study participants and study personnel were reported to be blinded to the allocation. In addition, two people with diabetes who used regular and neutral protamine Hagedorn (NPH) insulin stored in a clay pot during a two‐month period while living in a tent in the desert participated. </p> <p>Human insulin was stored in a refrigerator at 4 °C or in a zeer (a semi‐porous unglazed clay pot enabling water to slowly seep through the wall and evaporate, lowering the temperature of the remaining water). A glass jar was partially filled with desert sand and put in the centre of the zeer. A water bath was created by adding water outside the jar to the same level as that of the sand in the glass jar. Water was added to the mark (topped up) daily from a larger water storage zeer. The zeer was closed with a clay lid and kept in the shade. An exact replica, but without water (a dry zeer) was also used to store insulin and record temperatures. Additional bottles of insulin were kept outside in the shade, in the bathroom of an air‐conditioned house and in a refrigerator. Ten units (U) of insulin were removed twice daily from each insulin vial to simulate usage conditions. Temperature readings were taken at 7:00 hours or 12:00 hours during the six‐week storage period. </p> <p>To investigate insulin sensitivity, baseline blood samples were taken in fasting participants and insulin 0.1 U/kg bodyweight was intravenously applied. For 30 minutes after the injection, blood samples were drawn every five minutes. Study authors measured the fall in plasma glucose levels using a computerised best fit method. </p> <p>The mean temperatures were as follows: outside 38.3 °C (range 34 °C to 43 °C), insulin zeer 26.6 °C (range 25 °C to 27 °C), dry zeer 34.6 °C (range 30 °C to 39 °C), insulin vials stored in the shade 35.3 °C (range 31 °C to 39 °C), water zeer 26.7 °C (range 25 °C to 28 °C), bathroom 26.4 °C (range 25 °C to 27 °C) and refrigerator 4 °C. There were no changes in colour or appearance of the insulins. The mean fall in plasma glucose levels following reference insulin was 0.213 mmol/L/minute, whereas it was 0.192 mmol/L/minute following the zeer‐stored insulin, representing 9.9% less fall in glucose in the zeer‐stored insulin (very low‐certainty evidence). Investigators reported that the observed difference in the rate of glucose decline was not 'statistically significant'. The two participants with diabetes reported no changes in the appearance of insulin or adverse events and no changes in diabetic control. </p> <p>Study authors did not report on diabetic ketoacidosis, hypoglycaemic episodes, adverse events, health‐related quality of life or HbA1c. </p> <p>Certainty of the evidence was very low due to risk of bias (unclear randomisation and allocation concealment, indirectness (surrogate outcome, insufficient time frame) and imprecision (very small sample size, one study only)). </p> </section> <section id="CD015385-sec-0037"> <h4 class="title">In‐vitro studies</h4> <p>For an overview of the main results, see <a href="./full#CD015385-tbl-0002">summary of findings Table 2</a>. </p> <p>Of note, European and US Pharmacopeia (USP) stipulate that human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL (i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin) (<a href="./references#CD015385-bbs2-0104" title="European Pharmacopoeia (Ph. Eur), 11th Edition. Strasbourg: European Pharmacopoeia Commission, European Directorate for the Quality of Medicines (EDQM); 2023.">European Pharmacopoeia 2023</a>; <a href="./references#CD015385-bbs2-0146" title="US Pharmacopeia. Insulin Human Drug Products 100 IU/ml. Rockville, MD: United States Pharmacopeial Convention; 2016.">USP 2016</a>). No data exist clearly relating different insulin potencies to insulin efficacy (i.e. the lowering of blood glucose). However, it is evident that, for example, insulin 80 U/mL lowers blood glucose to a lesser degree than, for example, 90 U/mL. However, the clinical insulin effect depends on many individual factors (e.g. age, bodyweight, physical activity, dietary habits, comorbidities such as infections and blood glucose values before insulin injection). </p> <p>Due to considerable heterogeneous study data, it was not possible to draw up a straightforward evidence synthesis of publication results. Instead, <a href="#CD015385-tbl-0006">Table 3</a> provides an overview of data and key results from study publications. The included studies reported numerous methods, laboratory measurements and storage conditions. Study authors often applied reverse‐phase high‐performance liquid chromatography (RP‐HPLC) to measure insulin potency (<a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>; <a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a>; <a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a>; <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>; <a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a>; <a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>; <a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a>; <a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a>; <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>). Older publications cited methods that are rarely used today (e.g. radioimmunological activity) (<a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a>; <a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a>), degradation of protein (<a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a>), cultures in infusion broths (<a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a>), and short‐time plasma glucose levels after intravenous insulin injection (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>). Some study authors employed sophisticated methods (e.g. mass spectrometry (<a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>) or proton nuclear magnetic resonance spectroscopy (<sup>1</sup>H NMR) (<a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>)) for insulin concentration and newer methods to evaluate insulin protein structural changes (<a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>; <a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>). </p> <div class="table" id="CD015385-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Overview of data from study publications</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Type of insulin</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Injection and container device</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Maximum temperature</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Maximum storage period</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Main measurement(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Key results<sup>a</sup> </b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pilot clinical study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin in clay pot 26.6 °C<br/>Insulin in refrigerator 4 °C </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Plasma glucose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to 37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.7 U/mL (CV 4.6%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.184% total protein/week</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0122" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16(2):e0245372. [DOI: 10.1371/journal.pone.0245372]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 °C ‐ 37 °C<sup>b</sup><br/><br/><br/>37 °C<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks<br/>1 week / 2 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency<br/>Microbial contamination<br/>Protein structure </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: 101.3% (SD 2.3)<br/>IAI: 101.6% (SD 8.9)<br/>MI: 101.9% (SD 3.5)<br/>MI: −15.4% / SAI: −12.5%<br/>No microbial contamination<br/>No changes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −4.0 IU/mL (95% CI 4.9)<br/>IAI: 1.4 IU/mL (95% CI 2.3) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.9 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency<br/>Protein structure </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −2.4%<br/>IAI: −0.7%<br/>MI: −1.4%<br/>Small changes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency<br/>Bacterial growth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No changes<br/>No bacterial growth </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93–94% AUC</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein structure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Amorphous agglomerates (both at 4 °C and 37 °C)<br/>No changes in chemical stability </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −18%<br/>IAI: −14% </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein structure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small changes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.5% to +0.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI, IAI, MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>b</sup><br/>37 °C<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Within specifications <br/>Visual changes (agglomerates) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No changes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI, IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sterility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No signs of bacterial growth</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.3% (SD 2.4) AUC</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> <p>Sterility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −1.9% to +1.7%<br/>IAI: +0.7% to +4.7%<br/>MI: −1.0% to −1.7% </p> <p>No microbial growth</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>All insulin activity data refer to baseline (time zero). According to US Pharmacopeia (USP) human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL, i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin <br/><sup>b</sup>Oscillating temperatures<br/><sup>c</sup>Continuous temperature </p> <p>AUC: area under the curve; CI: confidence interval; CV: coefficient of variation; IAI: intermediate‐acting insulin; IU: insulin unit; MI: mixed insulin (short‐acting + intermediate‐acting insulin); SAI: short‐acting insulin; SD: standard deviation; U: unit. </p> </div> </div> <p>Applied temperature and storage of human insulin vials and cartridges/pens also varied across studies. Study authors investigated insulin potency at 24 °C for up to 42 days (<a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a>), at 30 °C for up to 10 weeks (<a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a>), and at 26.3 °C to 28.9 °C for up to four months (<a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>). Many authors investigated insulin potency (<a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>; <a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a>; <a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>; <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>), or structural changes of the insulin protein (<a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>; <a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>), at up to continuous 37 °C, ranging from 28 days (<a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>) to 26 weeks (<a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a>). Two publications applied fluctuating temperatures between 25 °C and 37 °C for 28 days to 12 weeks, mimicking real‐life conditions (<a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>). Two publications used additional stress tests, such as rotation of cartridges (<a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>) or shaking of insulin vials (<a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a>). </p> <p>Four studies reported twice‐daily insulin sampling simulating usage by people with diabetes (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>; <a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a>; <a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>). Multiple punctures of vials and cartridges as well as reduced volume of insulin in the container did not alter insulin potency. </p> <p>Investigations on prefilled syringes, important for people with visual or manual impairments, included a temperature range of 4 °C to 23 °C for 10 to 28 days (<a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a>; <a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a>; <a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a>; <a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a>). There was no clinically relevant loss of insulin activity, and no signs of microbial growth. </p> <p>Investigations on vials with different temperature and storage conditions showed no (<a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>, fluctuating temperatures at 25 °C to 37 °C for up to three months) or no clinically relevant reduction in insulin concentrations for short‐acting, intermediate‐acting and mixed insulin (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>; <a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>; <a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a>; <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>; <a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a>; <a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a>; <a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>). Two publications reported a more pronounced loss in insulin activity: <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> noted 18% after 28 days at 37 °C and 14% after 28 days at 37 °C for short‐acting and biphasic human insulin, respectively. <a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> noted a decrease of 17.2% after eight weeks at continuous 31 °C for NPH insulin. These authors also reported a decrease of 15.4% after one week at continuous 37 °C for premixed short‐acting/NPH insulin as well as a 12.5% decrease after two weeks at 37 °C for short‐acting insulin. </p> <p>Investigations on cartridges/pens did not show a decrease in insulin potency outside the specification limits after 28 days of fluctuating temperatures at 25 °C to 37 °C and agitation for intermediate‐acting and mixed insulin (<a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>). However, after continuous high temperatures over 28 days at 37 °C and agitation, there were visual changes (<a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>). Other investigators observed no reductions of insulin activity outside the specification limits after 28 days at 37 °C for intermediate‐acting insulin (<a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>), or insulin protein structural changes after 10 weeks at 37 °C for intermediate‐acting NPH insulin (<a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>). </p> <p>The following sections provide a detailed overview of the individual study data reported in publications. </p> </section> <section id="CD015385-sec-0038"> <h4 class="title">Studies on vials</h4> <p>Ten studies investigated storage conditions for insulin vials (for the pilot clinical study (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>) see above). </p> <p> <ul id="CD015385-list-0041"> <li> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a>: various insulin manufacturers provided soluble neutral human insulin 40 U/mL which were investigated by HPLC, using reversed phase and gel‐filtration chromatography. Preparations were shaken for 72 hours at 37 °C and at ambient temperature. Radioimmunological activity was tested and investigators inoculated parts of the insulin sediment on culture plates to look for bacterial growth. Investigations performed at ambient temperature showed the same molecular insulin weight as investigations performed at 37 °C. The material inoculated on culture plates showed no bacterial growth. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a>: single vials of short‐acting human insulin were stored under each of the following environmental conditions and in the laboratory: 4 °C in the dark; room temperature 19 °C to 24 °C in the dark; room temperature 18 °C to 25 °C in daylight; in direct sunlight on a window sill (8 °C to 35 °C); at 37 °C in the dark; and carried in the breast pocket of a shirt. Some vials were subjected to twice‐daily sampling (i.e. small amounts of insulin were removed to simulate injections). HPLC measurements were taken immediately after dispensing and at 2, 4, 6, 8, 10, 14, 18 and 26 weeks. The initial insulin content in human insulin vials was 98.2% (standard deviation (SD) 0.08) of total protein. None of the environmental conditions caused a significant loss of total protein during the six months of study. Human insulin kept at 4 °C and in the dark without sampling was associated with the slowest degradation (−0.069% total protein/week). The vials kept in direct sunlight and at 37 °C in the dark degraded most quickly (−0.749% total protein/week and −1.184% total protein/week, respectively). The slope estimates from the four vials kept at room temperature were similar. Repeated sampling only affected the degradation rate in the vials kept at 4 °C in the dark. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>: two human insulin formulations, short‐acting insulin and mixed insulin (30/70) were purchased from the open market from three different manufacturers. Human insulin formulations were stored at five different temperatures (i.e. 5 °C (refrigerator), 25 °C (air‐conditioned room), 26° (mud pot), 32 °C (room temperature) and 37 °C (room temperature in summer)). Samples were drawn from these vials every seven days for 28 days and analysed by HPLC. Study authors also performed an insulin tolerance test in rabbits showing a considerable decrease in blood glucose levels with respect to basal glucose (for details, see <a href="#CD015385-tbl-0007">Table 4</a>). All three brands of insulin for both formulations did not differ considerably in their insulin content during various sampling times and temperatures. There was no difference in concentration of insulin in vials stored at 25 °C and 26 °C compared to those stored at 5 °C on all five sampling days. Insulin in vials stored in the mud pot (26 °C) retained insulin potency. There was a 14% and 18% decrease in the concentration of short‐acting insulin in vials stored at 32 °C and 37 °C on day 28. There was an 11% and 14% decrease in the concentration of short‐acting insulin in biphasic insulin formulation in vials stored at 32 °C and 37 °C on day 28. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a>: intermediate‐acting insulin in vials were stored in a refrigerator at 2 °C to 8 °C and at room temperature at 22 °C to 24 °C. A modified HPLC assay was used to quantify insulin area under the curve (AUC) profiles under different storage conditions (i.e. time 0 (opening) and days 28, 35 and 42). Investigators could not confirm which peaks corresponded to metacresol preservative or insulin nor additional procedures to detect degradants. After 35 days at room temperature, the 12‐minute and 21‐minute peak ranged between 94% and 101% and 94% and 100% of time zero AUC reference values, respectively. After 42 days, the 12‐minute and 21‐minute peak was 93% and 94% of time zero AUC reference values, respectively. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a>: short‐acting and intermediate‐acting insulins were analysed for insulin concentration and stability by means of RP‐HPLC. Following storage for 30 months at 5 °C and handling as per procedure during the cold‐chain transport and during pharmacy storage samples were then: 1. left at 30 °C for six weeks to mimic in‐use impact (mimicking as per label conditions); and 2. left for four weeks at 30 °C to mimic non‐recommended handling conditions and then left at 30 °C for six weeks to mimic in‐use impact. None of the samples were outside the US Food and Drug Administration's (FDA) specifications. After 6 and 10 weeks at 30 °C, the mean decrease in insulin concentration for short‐acting insulin was 3.1 IU/mL (95% confidence interval (CI) 4.0) and 4.0 IU/mL (95% CI 4.9), respectively. After 6 and 10 weeks at 30 °C, the mean decrease in insulin concentration for intermediate‐acting insulin was 1.0 IU/mL (95% CI 1.9; as reported in publication) and 1.4 IU/mL (95% CI 2.3; as reported in publication), respectively. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>: vials containing short‐acting human insulin were stored according to manufacturer specifications until measurement of insulin content and stability by mass spectrometry. Formulations were sampled on days 1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 15, 16, 17, 54 and 85 upon storage at 4 °C, 22 °C and 37 °C in temperature‐controlled environments with electronic temperature monitoring (either refrigerator or incubators) to simulate various real‐life conditions. There was no systematic difference in insulin content between unopened vials (obtained from the pharmacy) and already used vials (obtained from hospital wards and people with diabetes). Screening for degradation products throughout the study was negative. The mean insulin concentrations (with coefficient of variation (CV)) over all measurements and 86 days were as follows: 4 °C: 98.6 U/mL (CV 5.5%); 22 °C: 99.4 U/mL (CV 5%); 37 °C: 98.7 U/mL (CV 4.6%). </p> </li> <li> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>: specifically investigated the influence of fluctuating temperatures on insulin thermostability, thereby mimicking cycling temperatures which are observed in hot regions and in conflict and humanitarian emergency settings. The study authors measured temperature fluctuations in the Dagahaley refugee camp (Northern Kenya) and observed oscillating temperatures between 25 °C and 37 ˚C with a 12‐hour cycle (starting at 25 ˚C, increasing to 37 ˚C in 12 hours, then back to 25 ˚C in 12 hours) which were replicated in a laboratory in Geneva (Switzerland) for a first series of vials. For a second series of samples, insulin was taken out daily to simulate a typical daily treatment with doses of 10 IU in the morning and 12 IU in the evening. In a third series, the effect of continuous (isothermal) exposure to high temperatures of 31 °C and 37 °C was investigated to compare results with data available in the literature. The two insulin formulations considered as essential medicines by the WHO (i.e. short‐acting insulin and intermediate‐acting NPH insulin) were exposed to a continuous temperature of 37 °C. Also, a series of mixed insulin vials were stored at ambient temperature in Kenya for four weeks of use by people with diabetes and brought back to Geneva for analysis. Insulin stored at 2 °C to 8 °C was used as positive control and heat‐degraded insulin as negative control analysing degradation after heating to 80 °C and agitation for 30 minutes. Study authors investigated three parameters: insulin potency by HPLC, conservation of the tridimensional conformation of insulin by circular dichroism and residual bioactivity by measuring insulin efficiency on insulin receptors. Visual inspection was performed according to European Pharmacopeia prescriptions. Concentrations of the preservatives phenol and metacresol indicating proper antimicrobial activity in the formulations were measured. Microbial contamination was investigated by taking transmission electron microscopy (TEM) images of the samples. Insulins studied were short‐acting insulin, intermediate‐acting NPH insulin and premixed short‐acting/NPH insulin (30% short‐acting insulin/70% NPH insulin) in vials. </p> <ul id="CD015385-list-0042"> <li> <p>Oscillating temperatures (25 °C to 37 °C): after 4 and 12 weeks, short‐acting insulin potency as compared to time zero (baseline) was 100.1% (SD 0.5) and 101.3% (SD 2.3), respectively. Results for NPH insulin were 101.3% (SD 1.3) and 101.6% (SD 8.9), respectively. Results for premixed short‐acting/NPH insulin were 100.6% (SD 1.6) and 101.9% (SD 3.5), respectively. Vials of mixed insulin returned from Kenya after four weeks of storage at ambient temperature at the individual's home were above 90% compared to the same mixed insulin exposed to four weeks of temperature cycling in the laboratory. None of the examined formulations showed visual changes in terms of yellowish colour or larger aggregates. After 12 weeks, phenol and metacresol concentrations were 92.4% to 94% and 92.7% to 97.7% of claimed values, respectively. There was no microbial contamination detected. Tridimensional conformation of insulin monomers was identical in all investigated samples. Mixed insulin under storage conditions oscillating between 25 °C and 37 °C for 12 weeks maintained bioactivity similar to insulin stored at 4 °C. Mixed insulin stored for four weeks out of refrigeration in a person's home in Kenya and mixed insulin at 25 °C to 37 °C for 12 weeks in the laboratory maintained bioactivity similar to insulin stored at 4 °C. The presence of air in the vials and multiple septa punctures had no impact on stability, and there was no difference in stability between insulin conditioned in pen cartridges and 10 mL glass vials. </p> </li> <li> <p>Isothermal temperatures (31 °C and 37 °C): after 1, 4 and 8 weeks at continuous 31 °C results for NPH insulin activity as compared to time zero were 100.2% (SD 6.3), 94.8% (SD 5.4) and 82.8% (SD 4.0), respectively. After one week at continuous 37 °C, premixed short‐acting/NPH insulin activity showed a 15.4% decrease, and after two weeks, short‐acting insulin activity showed a 12.5% decrease. </p> </li> <li> <p>In an additional stability study on premixed short‐acting/NPH insulin in vials (30% short‐acting insulin/70% NPH insulin) study authors investigated the following parameters (personal communication). </p> <ul id="CD015385-list-0043"> <li> <p>Temperature cycles between 17 °C and 45 °C: insulin formulations were stable.</p> </li> <li> <p>Proportion between 'night' and 'day' by changes in temperature cycles 25 °C to 37 °C with 14 hours of exposure to higher temperatures, defined as 'day' period: insulin formulations were stable over four weeks. Insulin concentrations were all in the range of 100% ± 10% of the value at time zero. </p> </li> <li> <p>Residual bioactivity of insulin and molecular conformation: an excellent correlation was found between potency determination by HPLC, tridimensional structure verification and residual bioactivity in living cell lines. </p> </li> </ul> </li> </ul> </li> <li> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>: vials containing short‐acting and intermediate‐acting human insulin were stored at 4 °C and 37 °C for five weeks with weekly sampling to study the formation of subvisible particles. Measurements included TEM to analyse the presence of agglomerates, thioflavin T (ThT) fluorescence to measure the formation of amyloid material and electrospray ionisation ion‐mobility spectrometry mass spectrometry (ESI‐IMS‐MS) to evaluate the formation of aggregates due to chemical degradation. Additionally, dynamic light scattering (DLS) monitored the oligomeric and particulate distribution of insulin, and size‐exclusion chromatography (SEC) was performed for additional evaluation of the products. No amyloid particles were detected after four weeks of storage. However, large amorphous agglomerates were observed at 35 days after first handling, both at 4 °C and 37 °C. The chemical stability of the investigated short‐acting human insulin was not affected. Overall, data suggested the formation of subvisible and submicrometre amorphous particulate matter in insulin shortly upon use. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>: vials containing human short‐acting, intermediate‐acting and mixed 30/70 insulin were stored in water‐tight bags, in open plastic containers, placed on a cupboard or high shelf, or in water‐tight bags in clay pots with a separate water compartment and all in shaded areas. Six families with a young person with T1DM attending the Diabetes Research Education and Management (DREAM) Trust in Nagpur, India participated in the study. Control vials of each insulin were also kept refrigerated at the DREAM Trust. All samples of each type of insulin came from one batch. Insulins were stored by families for one, two and four months, and then retrieved and refrigerated at the DREAM Trust. Samples were cold‐chain couriered to the University of Florida, USA and University of Gothenburg, Sweden and kept refrigerated until analysis. All insulin vials remained unused until analysis. At the University of Florida, analyses were conducted by HPLC. The University of Gothenburg used <sup>1</sup>H NMR. For all analyses, an insulin concentration of 100% ± 5% was acceptable according to the USP standard. In the analysis at the University of Florida, insulin activity at 26.3 °C to 28.9 °C and up to four months compared to baseline for short‐acting (<a href="#CD015385-fig-0002">Figure 2</a>), intermediate‐acting (<a href="#CD015385-fig-0003">Figure 3</a>), and mixed insulin (<a href="#CD015385-fig-0004">Figure 4</a>) ranged between −0.7% and −2.4%, −0.7% and +2.1%, and −1.8% and +0.8%, respectively. In the analysis performed at the University of Gothenburg, there was a subtle line width increase and slight peak shifts in nuclear magnetic resonance spectra, which correlated with storage time for non‐refrigerated samples. According to the study authors, this was probably due to altered conformation or multimerisation in a minor fraction of the insulin molecules. There was no loss of relative concentration using nuclear magnetic resonance. There was no decrease in total concentration in any of the insulin types observed as being larger than the precision of measurements (less than 1%), regardless of storage time or type of storage. The decline in mean potency for those samples stored in clay pots across all insulins at month four (0.5%) was lower than that for those stored in open boxes (3.6%). </p> </li> </ul> </p> <div class="table" id="CD015385-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Mean blood sugar levels in rabbits after intraperitoneal administration of regular human insulin stored at different temperatures for 24 days</span></div> <tbody> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Novo Nordisk human insulin (mean mg/dL (SEM))</b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>5 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>25 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>26 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>32 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>37 °C</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.6 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.3 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.1 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.8 (1.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.6 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.5 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.6 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.6 (1.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.8 (1.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.8 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.3 (1.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.6 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.5 (0.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.8 (1.3)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Eli Lilly and Company human insulin (mean mg/dL (SEM))</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 (2.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.3 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.5 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 (1.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.6 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.6 (1.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.3 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.3 (1.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.8 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.1 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.8 (1.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.1 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.1 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.0 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.3 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.8 (1.2)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>BIOCON human insulin (mean mg/dL (SEM))</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.3 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.1 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 (1.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.8 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.8 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.5 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.3 (1.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.5 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.5 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.8 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.5 (1.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.0 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.0 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.3 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.0 (1.1)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from table in <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>. </p> <p>min: minutes; SEM: standard error of the mean.</p> </div> </div> <div class="figure" id="CD015385-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix Pendsey 2023, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0002" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix Pendsey 2023, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0003" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Mixed human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix Pendsey 2023, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0004" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Mixed human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> </div> </section> <section id="CD015385-sec-0039"> <h4 class="title">Studies on cartridges/pens</h4> <p>Three studies investigated storage conditions for insulin cartridges/pens.</p> <p> <ul id="CD015385-list-0044"> <li> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>: short‐acting, intermediate acting and mixed human insulin cartridges were investigated to evaluate the combined effect of temperature and agitation. Study authors performed temperature cycling (25 °C to 37 °C) tests in an incubator unit combined with resuspensions conducted twice daily on a mechanical device outside the incubator unit. The incubator unit was calibrated within the temperature range 25 °C to 37 °C. The temperature changed from 25 °C to 37 °C over two hours, with 10‐hour periods at each temperature. The temperature was decreased from 37 °C to 25 °C over two hours and the cycle was repeated for 28 days. Cartridges were visually assessed by trained operators after resuspension on test days 0, 7, 14, 21 and 28. Cartridges were checked for visual changes compared to quiescent refrigerated control samples. For solutions, visual changes included changes in colour and clarity from a clear solution. For suspensions, visual changes included the presence of large aggregates (clumps), material adhering to the cartridge wall (frosting), or both. RP‐HPLC was used to determine total insulin activity. Additionally, study authors performed continuous high‐temperature (37 °C) exposure tests in an incubator unit combined with periodic daily agitation by rotation devices while still inside the incubator unit. The incubator unit was calibrated to 37 °C. The cartridges were rotated at 30 rotations per minute (rpm) for four hours by custom‐made rotators. Additional agitation was imparted on the test cartridges through resuspension outside the incubator unit. The resuspension machine was used after the cartridges were removed from the incubator unit and prior to visual assessment. The resuspension machine performed three sets of 10 rolls plus 10 inversions. Cartridges were visually assessed after resuspension by trained operators on test days 0, 2, 5, 7, 9, 11, 14, 17, 21, 24 and 28. Also, microscopy, particle size determination and electrophoretic mobility measurements were carried out. For short‐acting soluble insulin, all stress testing studies showed no change in the product for all conditions tested. For intermediate‐acting and mixed human insulin suspension, HPLC assays were within specification after 28 days of temperature cycling and agitation. Continuous high temperature testing of both suspension products resulted in an HPLC potency measurement for a visually unchanged cartridge that was within specifications after one week of testing. However, after continuous high temperature over 28 days, there were visual changes (agglomerate formations) observed. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a>: study authors investigated the effect of different temperatures in a tropical country on the stability of intermediate‐acting insulins after opening. Opened insulin pens were stored at room temperature, in a refrigerator (2 °C to 8 °C) or in an incubator (37 °C) for 28 days. Room temperature and humidity were recorded every hour throughout the study period. In the experimental group, all insulin pens were opened and flipped back and forth 20 times. Two units of insulin were discarded every day to simulate the daily usage by insulin‐treated people with diabetes. In the control group, an unopened insulin pen from each batch was stored in a refrigerator. All in‐use insulin pens were kept away from direct exposure to sunlight or artificial light. Insulin was analysed using ultra HPLC and the quantity of insulin was reported as mean and SD of AUC. During the study period, the mean room temperature was 29.7 °C (SD 2.8) (range 25.5 °C to 37.1 °C). The mean daytime temperature (6 a.m. to 7 p.m.) was 31.1 °C (SD 2.9) (range 27.1 °C to 37.1 °C) and the mean night‐time temperature (7 p.m. to 6 a.m.) was 28 °C (SD 1.3) (range 26 °C to 31 °C). The mean humidity in the room was 74.6% (SD 9) (range 50.0% to 89.5%). The mean humidity was 50% in the refrigerator and 38% in the incubator. The percent change in insulin quantity from baseline AUC after 28 days ranged from −2.6% to +1.4% and −1.5% to +0.7% at room temperature and incubator condition, respectively. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a>: insulin specimens were studied by means of infrared (IR) attenuated total reflection (ATR) spectroscopy for comparison of protein structural changes. Insulin cartridges contained intermediate‐acting human NPH insulin with a biological activity of 100 insulin units (IU)/3 mL. Samples were stored in climatic exposure cabinets at 0 °C, 20 °C and 37 °C for different durations (up to 10 weeks). Significant changes within the insulin samples at various storage temperatures due to misfolding and subsequent fibrillation allowed the assumption of a decrease in bioactivity. Especially under storage conditions at high temperature (37 °C), there was an increased quantity of β‐sheet fractions in ultrafiltrated insulin samples (non‐stabilised hormone purified by ultrafiltration, i.e. pure insulin without excipients) detected by band deconvolution, underlining protein structural misfolding. Compared to the ultrafiltrated insulin samples, there were only small shifts detected for the other formulations, suggesting that the added stabilisers were protecting the insulin effectively from accelerated misfolding. </p> </li> </ul> </p> </section> <section id="CD015385-sec-0040"> <h4 class="title">Studies on prefilled syringes</h4> <p>Four studies investigated storage conditions for prefilled plastic syringes.</p> <p> <ul id="CD015385-list-0045"> <li> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a>: insulin syringes of three manufacturers were filled with short‐acting insulin and stored at 4 °C for two weeks. After 1, 3, 7 and 14 days, the syringes were removed, and aliquots were taken for radioimmunoassay and radioreceptor determinations. Samples of refrigerated stock insulin served as controls. The insulin content of samples stored in plastic syringes for up to two weeks was similar to that of the stock controls and comparable in their degradation. Regarding biological potency of insulin, receptor‐binding isotherms were the same for the different types of insulin as well as for the type of storage. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a>: the stability and sterility of short‐acting, intermediate‐acting, mixed and extemporaneously prepared combination human insulin was evaluated after storage in 1 mL polypropylene syringes. For each type of insulin, 0.4 mL samples were withdrawn from multiple‐dose vials into polypropylene syringes and propylene‐ethylene copolymer syringes. Half of the syringes were placed in a plastic bag and kept at room temperature (22 °C to 23 °C), while the other half were placed in a plastic bag and kept in the refrigerator (3 °C to 5 °C). A vial of each type of insulin was maintained under the same conditions as the syringes. On days 1, 3, 7, 14, 21 and 28, three syringes stored at each temperature were removed, and the contents were analysed by HPLC for insulin potency, and metacresol and phenol concentrations. Study authors compared insulin potency data with the potency of insulin in the syringes on day 0. The concentrations of the preservatives on each test day were compared with the initial concentrations in the vials on day 0. The human insulins stored at 4 °C and 23 °C did not show a significant loss of activity in either type of syringe during the 28‐day test period (<a href="#CD015385-tbl-0008">Table 5</a>). The metacresol concentration decreased in all human insulins tested at room temperature during the 28‐day study. The percent change from baseline insulin concentration after 28 days at 4 °C for short‐acting insulin, intermediate‐acting insulin and mixed insulin ranged from −1.5% to +0.6%, +1.0% to +2.5% and −0.2% to 2.4%, respectively. The percent change from baseline concentration after 28 days at 23 °C for short‐acting insulin, intermediate‐acting insulin and mixed insulin ranged from −1.9% to +1.7%, +0.7% to +4.7% and −1.0% to −1.7%, respectively. The samples stored in polypropylene syringes tended to show a greater decrease in metacresol concentration than those stored in propylene‐ethylene copolymer syringes. Phenol concentrations were less affected than metacresol concentrations in both types of plastic syringes. Phenol concentrations decreased in the samples stored in plastic syringes at room temperature. None of the human insulin products that were drawn into the two different plastic syringes showed any microbial growth. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a>: syringes were filled with 10 U of short‐acting insulin (later withdrawn for commercial reasons by the manufacturer) and intermediate‐acting insulin. The prefilled insulin syringes were kept in a refrigerator at 4 °C for up to 10 days. After 10 days, insulin samples from each syringe were cultured concurrently in brain–heart infusion broth and in thioglycollate brain infusion broth. The samples were incubated at a temperature of 37 °C under aerobic and anaerobic conditions for up to seven days, with a daily check for growth. There were no signs of bacterial growth evident in any of the specimens. </p> </li> <li> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a>: the stability of short‐acting U‐500 insulin was evaluated after storage in polypropylene insulin syringes. Each syringe was filled with U‐500 insulin 0.25 mL (125 U). Samples were analysed immediately to establish day 0 stability values. The remaining syringes were kept capped inside an open tray in a laboratory refrigerator (3 °C to 5 °C). At days 7, 14, 21 and 28, syringes were removed for analysis by RP‐HPLC. In addition, a sample was drawn for a forced degradation sample. Study authors calculated the mean AUC for insulin peak. The percentage of the initial concentration remaining at days 7, 14, 21 and 28 was 97.8% (SD 0.6), 99.4% (SD 3.9), 99.9% (SD 2.4) and 93.3% (SD 2.4), respectively. </p> </li> </ul> </p> <div class="table" id="CD015385-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Stability of human insulin formulations in plastic syringes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Temperature</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Initial concentration</b> (units/mL) <b>(mean ± SD)</b> </p> </th> <th align="center" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Stability of human insulin in plastic syringes: % initial concentration remaining (mean ± SD)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 7</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 14</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 21</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 28</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Short‐acting human insulin (Humulin R)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.3 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.3 ± 1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.8 ± 3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.6 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.5 ± 3.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.3 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.6 ± 4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.0 ± 2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.2 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.9 ± 1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 1.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.0 ± 1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.1 ± 1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.4 ± 1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.6 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.7 ± 2.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.8 ± 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.2 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.1 ± 5.2</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Intermediate‐acting isophane human insulin (Humulin N)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.1 ± 1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 ± 2.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.4 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.1 ± 2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.0 ± 2.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.4 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.0 ± 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.8 ± 1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.5 ± 3.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.0 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.3 ± 3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.2 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.3 ± 2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.9 ± 3.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 2.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.4 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.2 ± 2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.7 ± 3.6</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Mixed human insulin: short‐acting human insulin + intermediate‐acting human insulin (Humulin N/R 70/30)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.7 ± 5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.9 ± 7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.1 ± 2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.8 ± 3.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.6 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.0 ± 5 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 3 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.8 ± 6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.4 ± 2.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.2 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.7 ± 3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98 9 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.7 ± 4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.0 ± 1.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.9 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 1.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 2.9</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Extemporaneous mixed insulin: intermediate‐acting human insulin + short‐acting human insulin (Humulin N/R 70/30)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.5 ± 2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.6 ± 3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.4 ± 5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.6 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 4.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.2 ± 2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.2 ± 1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.4 ± 4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.3 ± 6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96.2 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.6 ± 3.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.2 ± 5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.0 ± 4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.7 ± 6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96.9 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 2.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.5 ± 4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102 5 ± 5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.5 ± 6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 ± 3.0</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from table 1 in <a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> <p>P: Plastipak (polypropylene); SD: standard deviation; T: Terumo (propylene‐ethylene copolymer). </p> </div> </div> </section> </section> <section id="CD015385-sec-0041"> <h3 class="title" id="CD015385-sec-0041">Data from manufacturers</h3> <p>Most data below refer to unopened containers (vials, cartridges) being punctured only once for analysis, which is standard procedure throughout the pharmaceutical industry. </p> <p>Four manufacturers (BIOTON (biosimilar manufacturer), Eli Lilly and Company, Novo Nordisk and Sanofi) provided data on thermostability of human insulin. We did not obtain data from Gan and Lee Pharmaceuticals (biosimilar manufacturer). For an overview of main results, see <a href="./full#CD015385-tbl-0003">summary of findings Table 3</a>. </p> <p>As Sanofi permanently discontinued the production of its human insulins Insuman rapid 100 IU/mL, Insuman rapid SoloStar 100 IU/mL, Insuman basal 100 IU/mL, Insuman basal SoloStar 100 IU/mL, Insuman comb 25 100 IU/mL and Insuman comb 25 SoloStar 100 IU/mL worldwide, data provided by the manufacturer could not be included in this review (<a href="./references#CD015385-bbs2-0136" title="Editor. Sanofi to discontinue Insuman® insulins over upcoming months. diabetestimes.co.uk/sanofi-to-discontinue-insuman-insulins-over-upcoming-months (assessed 11 June 2023).">Sanofi 2023a</a>; <a href="./references#CD015385-bbs2-0137" title="Information letter from Sanofi-Aventis Deutschland GmbH on the worldwide discontinuation of the production of the medicinal products Insuman basal, Insuman rapid and Insuman comb25 [Informationsschreiben der Sanofi-Aventis Deutschland GmbH zur weltweiten Einstellung der Produktion der Arzneimittel INSUMAN BASAL, INSUMAN RAPID und INSUMAN COMB25]. www.bfarm.de/SharedDocs/Arzneimittelzulassung/Lieferengpaesse/DE/2023/info_insulin_human_20230525.html?nn=471334 (assessed 29 June 2023).">Sanofi 2023b</a>). </p> <p>BIOTON provided data on short‐acting human insulin 40 IU/mL vials after 28 and 42 days at 30 °C: insulin activity, A21 desamido insulin, impurities, total zinc, metacresol and pH all remained within reference values. BIOTON also provided data on short‐acting human insulin 100 IU/mL vials after one, three and six months at 25 °C: insulin activity, A21 desamido insulin, impurities, total zinc, metacresol and pH all remained within reference values. Loss of insulin activity, calculated as percentage change compared to baseline after one, three and six months was 1.1%, 1.0% and 1.7%, respectively. </p> <p>Eli Lilly and Company provided summary data: at below 25 °C short‐acting, intermediate‐acting and mixed insulin could be stored for up to 25 days before start use and then 28 days for patient in‐use. At below 30 °C, short‐acting, intermediate‐acting and mixed insulin could be stored for up to 12 days before start use and then 28 days for patient in‐use. All product quality attributes met established acceptance criteria. </p> <p>The results presented below are based on data from Novo Nordisk, which provided the most detailed information. Insulin concentrations were measured by HPLC. </p> <p>We used the mean concentration from refrigerated samples at time zero (baseline) as a reference value to assess changes in the following parameters, if provided (depending on insulin formulation different reference values were applicable). </p> <p> <ul id="CD015385-list-0046"> <li> <p>Insulin activity 100 IU/mL (activity, potency or concentration; reference value: 95 IU/mL to 105 IU/mL) </p> </li> <li> <p>A21 desamido insulin (reference value: 1.5% or less), degradation product</p> </li> <li> <p>A21 desamido insulin + N‐oxalyl desPheB1 (desPhe) insulin (reference value: 1.54% or less), degradation product </p> </li> <li> <p>B3 desamido insulin (reference value: 6.54% or less), degradation product</p> </li> <li> <p>High molecular weight proteins (HMWP) (reference value: 2% or less, 3% or less)</p> </li> <li> <p>Other related proteins (ORP) (reference value: 3.0% or less, 4.5% or less)</p> </li> <li> <p>Particulate matter (particles 10 µm/container or less, reference value: 6000 or less; particles 25 µm/container or less, reference value: 600 or less) </p> </li> <li> <p>Macroscopic appearance</p> </li> <li> <p>Metacresol (reference value: 1.35 mg/mL to 1.65 mg/mL, 2.7 mg/mL to 3.3 mg/mL), preservative/stabiliser</p> </li> <li> <p>Phenol (reference value: 0.59 mg/mL to 0.72 mg/mL), preservative/stabiliser</p> </li> <li> <p>pH (reference value: 6.9 to 7.5, 7.0 to 7.8)</p> </li> <li> <p>Zinc (reference value: 10.0 µg/mL to 40.0 µg/mL, 40.0 µg/mL or less), preservative/stabiliser</p> </li> <li> <p>Sterility, bacterial endotoxins</p> </li> </ul> </p> <section id="CD015385-sec-0042"> <h4 class="title">Results for short‐acting insulins</h4> <section id="CD015385-sec-0043"> <h5 class="title">Storage at 25 °C</h5> <section id="CD015385-sec-0044"> <h6 class="title">Insulin potency</h6> <p><a href="#CD015385-fig-0005">Figure 5</a> and <a href="#CD015385-fig-0006">Figure 6</a> show insulin assays for vials and cartridges, respectively, stored at 25 °C between 1 and 12 months. </p> <div class="figure" id="CD015385-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0005" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL)CI: confidence interval; IU: international units." data-id="CD015385-fig-0006" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL) </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <section id="CD015385-sec-0045"> <p><b>Loss of insulin activity (percentage change compared to baseline)</b></p> <p> <ul id="CD015385-list-0047"> <li> <p>After one month, mean loss for vials was 0.4% (SD 0.3) and for cartridges 0.5% (SD 0.4). </p> </li> <li> <p>After three months, mean loss for vials was 1.8% (SD 0.6) and for cartridges 1.8% (SD 0.6). </p> </li> <li> <p>After six months, mean loss for vials was 3.5% (SD 0.4) and for cartridges 3.2% (SD 0.5). </p> </li> <li> <p>After 12 months, mean loss for vials was 7.4% (SD 0.6) and for cartridges 6.5% (SD 0.5). </p> </li> </ul> </p> </section> </section> <section id="CD015385-sec-0046"> <h6 class="title">A21 desamido insulin, A21 desamido insulin plus desPhe, B3 desamido insulin</h6> <p>Mean values for A21 desamido insulin, A21 desamido insulin plus desPhe and B3 desamido insulin in vials or cartridges were in range for up to 12 months, except for B3 desamido insulin at month 12 (6.63%). </p> </section> <section id="CD015385-sec-0047"> <h6 class="title">High molecular weight proteins, other related proteins</h6> <p>At time zero, mean value for HMWP was 0.1% for vials. After 1, 3, 6 and 12 months, HMWP increased to 0.3%, 0.6%, 1.1% and 2.2%, respectively. </p> <p>At time zero, mean value for HMWP was 0.2% for cartridges. After 1, 3, 6 and 12 months, HMWP increased to 0.3%, 0.6%, 1.0% and 1.8%, respectively. </p> <p>ORP were in range up to six months. After 12 months, the mean ORP increased to 7.2% (vials) and 6.2% (cartridges). </p> </section> <section id="CD015385-sec-0048"> <h6 class="title">Particulate matter</h6> <p>Macroscopy and particles per container complied with specifications.</p> </section> <section id="CD015385-sec-0049"> <h6 class="title">Bacterial endotoxins, sterility</h6> <p>Except for time zero, there were no data available.</p> </section> <section id="CD015385-sec-0050"> <h6 class="title">Metacresol</h6> <p>Mean metacresol values remained within reference range.</p> </section> <section id="CD015385-sec-0051"> <h6 class="title">Zinc</h6> <p>Mean zinc values remained within reference range.</p> </section> <section id="CD015385-sec-0052"> <h6 class="title">pH</h6> <p>Mean pH values remained within reference range.</p> </section> </section> <section id="CD015385-sec-0053"> <h5 class="title">Storage at 37 °C</h5> <section id="CD015385-sec-0054"> <h6 class="title">Insulin potency</h6> <p><a href="#CD015385-fig-0007">Figure 7</a> and <a href="#CD015385-fig-0008">Figure 8</a> show insulin assays for vials and cartridges stored at 37 °C between one and three months. After one month, insulin content either remained within specifications for both vials and cartridges or showed a small decline below the lower limit, which was comparable to results after two months. </p> <div class="figure" id="CD015385-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0007" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0008" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <section id="CD015385-sec-0055"> <p><b>Loss of insulin activity (percentage change compared to baseline)</b></p> <p> <ul id="CD015385-list-0048"> <li> <p>After one month, mean loss for vials was 2.2% (SD 0.6) and for cartridges 2.8% (SD 0.3). </p> </li> <li> <p>After two months, mean loss for vials was 5.7% (SD 0.7) and for cartridges 5.7% (SD 1.5). </p> </li> <li> <p>After three months, mean loss for vials was 8.6% (SD 0.6) and for cartridges 8.3% (SD 0.8). </p> </li> </ul> </p> </section> </section> <section id="CD015385-sec-0056"> <h6 class="title">A21 desamido insulin, A21 desamido insulin plus desPhe, B3 desamido insulin</h6> <p>Mean values for A21 desamido insulin, A21 desamido insulin plus desPhe and B3 desamido insulin in vials and cartridges were in range for up to three months. </p> </section> <section id="CD015385-sec-0057"> <h6 class="title">High molecular weight proteins, other related proteins</h6> <p>At time zero, mean value for HMWP was 0.1% for vials. After one, two and three months, mean HMWP values increased to 1.0%, 2.0% and 3.0%, respectively.<br/>At time zero, mean value for HMWP was 0.2% for cartridges. After one, two and three months, mean HMWP values increased to 1.0%, 2.0% and 2.9%, respectively. </p> <p>ORP were in range after one month. After two and three months, mean ORP in vials increased to 5.1% and 7.8%, respectively. After two and three months, mean ORP in cartridges increased to 5.5% and 7.9%, respectively. </p> </section> <section id="CD015385-sec-0058"> <h6 class="title">Particulate matter</h6> <p>Macroscopy and particles per container complied with specifications.</p> </section> <section id="CD015385-sec-0059"> <h6 class="title">Bacterial endotoxins, sterility</h6> <p>Except for baseline, there were no data available.</p> </section> <section id="CD015385-sec-0060"> <h6 class="title">Metacresol</h6> <p>Mean metacresol values remained within reference range.</p> </section> <section id="CD015385-sec-0061"> <h6 class="title">Zinc</h6> <p>Mean zinc values remained within reference range.</p> </section> <section id="CD015385-sec-0062"> <h6 class="title">pH</h6> <p>Mean pH values remained within reference range.</p> </section> </section> <section id="CD015385-sec-0063"> <h5 class="title">Storage at 5 °C</h5> <p>For reasons of comparison, we only report insulin potency data at optimal storage conditions (refrigerator). </p> <section id="CD015385-sec-0064"> <h6 class="title">Insulin potency</h6> <p><a href="#CD015385-fig-0009">Figure 9</a> and <a href="#CD015385-fig-0010">Figure 10</a> show insulin assays for vials and cartridges stored at 5 °C between 12 and 24 months. Up to 30 months, insulin content remained within specifications for both vials and cartridges. </p> <div class="figure" id="CD015385-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0009" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Short‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0010" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Short‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <p>If refrigerated (5 °C) there was a minimal loss of insulin, for example, after 24 months of storage, mean loss for vials was 0.7% (SD 0.4) and for cartridges 1.2% (SD 0.6). </p> </section> </section> </section> <section id="CD015385-sec-0065"> <h4 class="title">Results for intermediate‐acting insulins</h4> <section id="CD015385-sec-0066"> <h5 class="title">Storage at 25 °C</h5> <section id="CD015385-sec-0067"> <h6 class="title">Insulin potency</h6> <p><a href="#CD015385-fig-0011">Figure 11</a> and <a href="#CD015385-fig-0012">Figure 12</a> show insulin assays for vials and cartridges stored at 25 °C between 1 and 12 months. </p> <div class="figure" id="CD015385-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0011" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0012" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> </div> <section id="CD015385-sec-0068"> <p><b>Loss of insulin activity (percentage change compared to baseline)</b></p> <p> <ul id="CD015385-list-0049"> <li> <p>After one month, mean loss for vials was 0.7% (SD 0.4) and for cartridges 0.5%.</p> </li> <li> <p>After three months, mean loss for vials was 1.2% (SD 0.5) and for cartridges 1.9%.</p> </li> <li> <p>After six months, mean loss for vials was 2.0% (SD 0.4) and for cartridges 2.3%.</p> </li> <li> <p>After 12 months, mean loss for vials was 3.4% (SD 0.7) and for cartridges 3.9%.</p> </li> </ul> </p> </section> </section> <section id="CD015385-sec-0069"> <h6 class="title">High molecular weight proteins, other related proteins</h6> <p>At time zero, mean value for HMWP was 0.2% for vials. After 1, 3, 6 and 12 months, HMWP increased to 0.3%, 0.6%, 1.0% and 1.8%, respectively. <br/>At time zero, mean value for HMWP was 0.2% for cartridges. After 1, 3, 6 and 12 months, HMWP increased to 0.4%, 0.7%, 1.0% and 1.5%, respectively. </p> <p>ORP were in range for all measurements, except after 12 months of storage for cartridges where ORP increased to 3.1%. </p> </section> <section id="CD015385-sec-0070"> <h6 class="title">Particulate matter</h6> <p>There were no data available.</p> </section> <section id="CD015385-sec-0071"> <h6 class="title">Bacterial endotoxins, sterility</h6> <p>There were no data available.</p> </section> <section id="CD015385-sec-0072"> <h6 class="title">Metacresol</h6> <p>Mean metacresol values remained within reference range.</p> </section> <section id="CD015385-sec-0073"> <h6 class="title">Phenol</h6> <p>Mean phenol values remained within reference range.</p> </section> <section id="CD015385-sec-0074"> <h6 class="title">Zinc</h6> <p>Mean zinc values remained within reference range.</p> </section> <section id="CD015385-sec-0075"> <h6 class="title">pH</h6> <p>Mean pH values remained within reference range.</p> </section> </section> <section id="CD015385-sec-0076"> <h5 class="title">Storage at 37 °C</h5> <section id="CD015385-sec-0077"> <h6 class="title">Insulin potency</h6> <p><a href="#CD015385-fig-0013">Figure 13</a> and <a href="#CD015385-fig-0014">Figure 14</a> show insulin assays for vials and cartridges stored at 37 °C between one and three months. </p> <div class="figure" id="CD015385-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0013" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0014" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> </div> <section id="CD015385-sec-0078"> <p><b>Loss of insulin activity (percentage change compared to baseline)</b></p> <p> <ul id="CD015385-list-0050"> <li> <p>After one month, mean loss for vials was 1.8% (SD 0.3) and for cartridges 1.4%.</p> </li> <li> <p>After two months, mean loss for vials was 3.8% (SD 0.4) and for cartridges 3.0%.</p> </li> <li> <p>After three months, mean loss for vials was 5.3% (SD 1.0) and for cartridges 4.7%.</p> </li> </ul> </p> </section> </section> <section id="CD015385-sec-0079"> <h6 class="title">High molecular weight proteins, other related proteins</h6> <p>At time zero, mean value for HMWP was 0.2% for vials. After one, two and three months, mean HMWP values increased 0.9%, 1.9% and 2.5%, respectively.<br/>At time zero, mean value for HMWP was 0.2% for cartridges. After one, two and three months, mean HMWP values increased to 0.8%, 1.5% and 2.1%, respectively. </p> <p>ORP were in range after one and two months. After three months, ORP increased to 4.0% (vials) and 3.3% (cartridges). </p> </section> <section id="CD015385-sec-0080"> <h6 class="title">Particulate matter</h6> <p>There were no data available.</p> </section> <section id="CD015385-sec-0081"> <h6 class="title">Bacterial endotoxins, sterility</h6> <p>There were no data available.</p> </section> <section id="CD015385-sec-0082"> <h6 class="title">Metacresol</h6> <p>Mean metacresol values remained within reference range.</p> </section> <section id="CD015385-sec-0083"> <h6 class="title">Phenol</h6> <p>Mean phenol values remained within reference range.</p> </section> <section id="CD015385-sec-0084"> <h6 class="title">Zinc</h6> <p>Mean zinc values remained within reference range.</p> </section> <section id="CD015385-sec-0085"> <h6 class="title">pH</h6> <p>Mean pH values remained within reference range.</p> </section> </section> <section id="CD015385-sec-0086"> <h5 class="title">Storage at 5 °C</h5> <p>For reasons of comparison, we only reported insulin potency data at optimal storage conditions (refrigerator). </p> <section id="CD015385-sec-0087"> <h6 class="title">Insulin potency</h6> <p><a href="#CD015385-fig-0015">Figure 15</a> and <a href="#CD015385-fig-0016">Figure 16</a> show insulin assays for vials and cartridges stored at 5 °C between 12 and 24 months. Up to 24 months, insulin content remained within specifications for both vials and cartridges. </p> <div class="figure" id="CD015385-fig-0015"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 15</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0015" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-15.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <div class="figure" id="CD015385-fig-0016"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 16</div> </div> <hr class="top"/><img alt="Intermediate‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0016" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-16.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> </div> <p>If refrigerated (5 °C), there was a minimal loss of insulin, for example, after 24 months of storage, mean loss for vials was 0.6% (SD 0.6) and for cartridges 0.1% (0.6). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD015385-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD015385-sec-0088"></div> <section id="CD015385-sec-0089"> <h3 class="title" id="CD015385-sec-0089">Summary of main results</h3> <p>We utilised two information sources, that is, study publications and previously unpublished data from pharmaceutical manufacturers. </p> <p>One pilot clinical study reporting on plasma glucose after intravenous insulin injection showed no difference between clay pot‐stored insulin and insulin stored in a refrigerator. Apart from two studies reporting a more pronounced loss in insulin activity, the majority of studies on vials and cartridges/pens using different temperature and storage conditions showed no clinically relevant decreases in insulin concentrations. Also, oscillating temperatures between 25 °C and 37 °C for up to three months resulted in no loss of insulin activity. Multiple punctures of vials and cartridges imitating in‐use periods by people with diabetes did not result in clinically relevant decreases in insulin activity. Investigations on prefilled syringes showed no decrease in insulin potency or signs of microbial growth. Thermostability studies from pharmaceutical companies manufacturing human insulin investigating storage conditions at up to 25 °C for a maximum of six months and at up to 37 °C for a maximum of two months did not show a clinically relevant change in insulin activity. </p> </section> <section id="CD015385-sec-0090"> <h3 class="title" id="CD015385-sec-0090">Overall completeness and applicability of evidence</h3> <p>We identified one pilot clinical study (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>). Only a few studies evaluated mixed human insulin (<a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>; <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>; <a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a>; <a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a>; <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>). We found no data on continuous subcutaneous insulin infusion (CSII) pumps, which would be important due to the impact of elevated temperature exposure and mechanical stress on the integrity of human insulin, as CSII pumps are worn close to the body. </p> <p>Unfortunately, data on human insulin storage conditions for people living in cold climates are scarce (<a href="./references#CD015385-bbs2-0123" title="KhuranaG , GuptaVK . Effect on insulin upon storage in extreme climatic conditions (temperature and pressure) and their preventive measures. Journal of Social Health and Diabetes2019;7(1):6-10. [DOI: 10.1055/s-0039-1692371]">Khurana 2019</a>). People living in cold climates have to find innovative ways to protect insulin: during the winter in the Himalayan areas, some people wear warm clothes made up of sheep and yolk wool to protect them from severe cold. One such cloth is an abdominal binder which may be used to wrap insulin vials and pens in multiple layers in the abdominal binder where temperatures range between 5 °C and 10 °C (<a href="./references#CD015385-bbs2-0123" title="KhuranaG , GuptaVK . Effect on insulin upon storage in extreme climatic conditions (temperature and pressure) and their preventive measures. Journal of Social Health and Diabetes2019;7(1):6-10. [DOI: 10.1055/s-0039-1692371]">Khurana 2019</a>). </p> <p>There are concerns that the measured and actual biological potency of insulin might differ due to misfolding of the insulin molecules and subsequent fibrillation if subjected to higher temperatures (<a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a>; <a href="./references#CD015385-bbs2-0099" title="DelbeckS , KrolinskiA , DederichY , StoppelkampS , HeiseHM . A novel approach for the assessment of insulin potency by glycemic monitoring of an insulin-dependent human cell line. Journal of Diabetes Science and Technology2020;14(3):691-2. [DOI: 10.1177/1932296819895541]">Delbeck 2020a</a>; <a href="./references#CD015385-bbs2-0100" title="DelbeckS , HeiseHM . FT-IR versus EC-QCL spectroscopy for biopharmaceutical quality assessment with focus on insulin-total protein assay and secondary structure analysis using attenuated total reflection. Analytical and Bioanalytical Chemistry2020;412(19):4647-58. [DOI: 10.1007/s00216-020-02718-1]">Delbeck 2020b</a>). <a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> reported findings in ultrafiltrated insulin samples (i.e. non‐stabilised pure insulin without excipients) of protein structural misfolding, possibly reducing insulin potency. However, added stabilisers protected intermediate‐acting human insulin effectively from accelerated misfolding. There are also in‐vitro study reports showing that metacresol had an inhibitory effect on amyloid fibrillation, which is thought to be immunogenic, potentially reducing insulin efficacy and causing allergic reactions (<a href="./references#CD015385-bbs2-0130" title="OhnoY , SekiT , KojimaY , MikiR , EgawaY , HosoyaO , et al. Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations. Journal of Pharmaceutical Health Care and Sciences2019;5:22. [DOI: 10.1186/s40780-019-0151-5]">Ohno 2019</a>). Another report indicated excellent correlation between potency determination by HPLC, tridimensional insulin structure verification and residual bioactivity in living cell lines (<a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>). Finally, one study investigating the formation of subvisible particles in short‐acting human insulin showed that amorphous aggregates developed within weeks of handling, regardless of storage temperature at 4 °C or 37 °C (<a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a>). </p> <p>Even without access to reliable refrigeration, there are simple ways to prevent insulin from overheating. Several studies demonstrated the efficacy of various cooling devices, such as clay pots filled with water or wet sand and the placement of insulin inside (<a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a>; <a href="./references#CD015385-bbs2-0028" title="GillG , PriceC , EnglishP , Eriksson-LeeJ . Traditional clay pots as storage containers for insulin in hot climates. Tropical Doctor2002;32(4):237-8. [DOI: 10.1177/004947550203200421]">Gill 2002</a>; <a href="./references#CD015385-bbs2-0029" title="GilliganMM , LinnesJC , vonOettingenJE , AltenorK . From toy to tool: using water beads for insulin storage in Haiti. Pediatric Diabetes2021;22(5):729-33. [DOI: 10.1111/pedi.13167]">Gilligan 2021</a>; <a href="./references#CD015385-bbs2-0123" title="KhuranaG , GuptaVK . Effect on insulin upon storage in extreme climatic conditions (temperature and pressure) and their preventive measures. Journal of Social Health and Diabetes2019;7(1):6-10. [DOI: 10.1055/s-0039-1692371]">Khurana 2019</a>; <a href="./references#CD015385-bbs2-0053" title="OgleGD , AbdullahM , MasonD , JanuszewskiAS , BesanconS . Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques. Diabetic Medicine2016;33(11):1544-53. [DOI: 10.1111/dme.13194]">Ogle 2016</a>; <a href="./references#CD015385-bbs2-0055" title="PendseyS . Keeping insulin cool naturally – the DREAM Trust storage system. Diabetes Voice2006;51(Special Issue):19. ">Pendsey 2006</a>; <a href="./references#CD015385-bbs2-0145" title="TaerahkunS , SriphrapradangC . Efficacy of alternative cooling devices used for insulin storage without refrigeration under hot-humid environment. Annals of Medicine2022;54(1):1118-25. [DOI: 10.1080/07853890.2022.2067355]">Taerahkun 2022</a>). </p> <p>More studies are needed on opened or in‐use vials and cartridges to investigate potential microbial ingress risk after multiple punctures of the container. </p> </section> <section id="CD015385-sec-0091"> <h3 class="title" id="CD015385-sec-0091">Certainty of the evidence</h3> <p>Extensive data from manufacturers of human insulin appeared reliable. Due to the objective measurements of insulin activity and other factors in the manufacturing process, we have confidence in the results provided. These investigations also appeared to be part of the approval process for the respective insulins, with drug regulatory authorities' overview of quality assurance. However, manufacturers' data on various storage conditions took place under optimal laboratory conditions (i.e. incubators assured continuous temperature conditions). </p> </section> <section id="CD015385-sec-0092"> <h3 class="title" id="CD015385-sec-0092">Agreements and disagreements with other reviews</h3> <p>We found no other reviews on this topic, apart from one narrative review addressing general aspects of insulin storage during the supply chain, highlighting the need for practical storage recommendations especially in homes of people with diabetes (<a href="./references#CD015385-bbs2-0114" title="HeinemannL , BrauneK , CarterA , ZayaniA , KrämerLA . Insulin storage: a critical reappraisal. Journal of Diabetes Science and Technology2021;15(1):147-59. [DOI: 10.1177/1932296819900258]">Heinemann 2021</a>). </p> <p>Contrary to other studies and data from manufacturers of human insulin, two studies described a pronounced loss in insulin activity at continuous temperatures of 37 °C after one or two weeks (<a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a>) and after 28 days (<a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>). However, insulin in vials stored in a mud pot that reduced outside temperatures to 26 °C retained insulin potency (<a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>). </p> </section> <section id="CD015385-sec-0093"> <h3 class="title" id="CD015385-sec-0093">Strengths and weaknesses of the review</h3> <p>Strengths of our review include our extensive search of the literature for relevant studies, with no language or date restrictions, and our detailed scrutiny of all references listed in all included studies and (systematic) reviews. We also established an email alert service for MEDLINE via OvidSP that was run on a weekly basis to identify newly published studies. In addition, we contacted pharmaceutical manufacturers of human insulin and received previously unpublished thermostability data. </p> <p>A potential weakness of our review is its body of evidence (i.e. mainly laboratory studies). For laboratory studies investigating loss of insulin potency at varying temperatures over time, there are no published validated methods to investigate risk of bias. However, shared data from pharmaceutical manufacturers of human insulin probably have a low risk of bias due to the objective measurements which were used in the thermostability investigations. Moreover, these analyses apparently formed part of the drug approval process under scrutiny from drug regulatory authorities in order to establish safety margins of insulin storage. </p> <p>Due to distinct variation in methods, laboratory measurements and storage conditions reported in the included studies, it was not possible to establish a straightforward evidence synthesis of publication results. Instead, we tried to provide a transparent overview of data and key results from study publications. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD015385-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD015385-fig-0001" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix Pendsey 2023, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0002" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Short‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix Pendsey 2023, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0003" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Mixed human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix Pendsey 2023, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0004" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-04.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Mixed human insulin assay (mean IU/mL with standard deviation) stored at 26.3 °C to 28.9 °C between baseline (month 0) and up to 4 months (data calculated from supplementary appendix <a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a>, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0005" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-05.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Short‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL)CI: confidence interval; IU: international units." data-id="CD015385-fig-0006" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-06.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Short‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL) </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0007" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-07.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Short‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0008" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-08.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Short‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0009" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-09.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Short‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Short‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0010" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-10.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Short‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-11" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0011" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-11.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for vials stored at 25 °C between baseline and up to 12 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-12" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0012" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-12.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for cartridges stored at 25 °C between baseline and up to 12 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-13" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0013" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-13.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for vials stored at 37 °C between baseline and up to 3 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-14" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).IU: international units." data-id="CD015385-fig-0014" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-14.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for cartridges stored at 37 °C between baseline and up to 3 months (one batch data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-15" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0015" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-15.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 15</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for vials stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015385-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/urn:x-wiley:14651858:media:CD015385:CD015385-FIG-16" target="_blank"><b></b></a></p> </div><img alt="Intermediate‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL).CI: confidence interval; IU: international units." data-id="CD015385-fig-0016" src="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-16.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_t/tCD015385-FIG-16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 16</div> <div class="figure-caption"> <p>Intermediate‐acting human insulin assay for cartridges stored at 5 °C between baseline and up to 24 months (data from Novo Nordisk, insulin reference value 95 IU/mL to 105 IU/mL). </p> <p>CI: confidence interval; IU: international units.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/media/CDSR/CD015385/image_n/nCD015385-FIG-16.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD015385-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Clinical studies</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Patient or population:</b> healthy physicians<br/><b>Setting:</b> outpatients, opened vials<br/><b>Intervention:</b> neutral human insulin, stored in a refrigerator at 4 °C<br/><b>Comparison:</b> neutral human insulin, stored in a zeer<sup>a</sup> at a mean of 26.6 °C </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>№ of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Effect</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Potency/bioactivity parameters of human insulin</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diabetic ketoacidosis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Hypoglycaemic episodes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Health‐related quality of life</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HbA1c</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean fall in plasma glucose levels</b> (mmol/L/min) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intravenous injection of 0.1 U/kg bodyweight of human insulin with blood samples taken every 5 min up to 30 min following the injection. </p> <p>Refrigerator insulin (mean 4 °C, 6 weeks' storage): 0.213 mmol/L/min</p> <p>Zeer‐stored insulin (mean 26.6 °C, 6 weeks' storage): 0.192 mmol/L/min</p> <p>Quote: "The observed difference in the rate of decline of glucose following insulin stored in a zeer, and that … being stored in a refrigerator, was not statistically significant." </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>HbA1c:</b> glycosylated haemoglobin A1c; <b>min:</b> minute; <b>RCT:</b> randomised controlled trial; <b>U:</b> unit. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Zeer: a clay pot that was unglazed, enabling water to slowly seep through the wall and evaporate, thus lowering the temperature of the remaining water. A glass jar with partially filled desert sand was put in the centre of the zeer. A water bath was created by adding water outside the jar to the same level as that of the sand in the glass jar. Water was added to the mark (topped up) daily. The zeer was closed with a clay lid and kept in the shade.<br/><sup>b</sup>Downgraded three levels due to the risk of bias (unclear randomisation and allocation concealment), indirectness (surrogate outcome, insufficient time frame) and imprecision (very small sample size, one study only). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Clinical studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD015385-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Published in‐vitro studies</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: insulin potency<sup>a</sup> measured by HPLC (mean % change compared to baseline)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 °C / 37 °C (28 days): −14% / −18%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 °C / 37 °C (28 days)<sup>b</sup>: −11% / −14% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Probably unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): +0.1% / +1.3%<br/>37 °C<sup>d</sup> (2 weeks): −12.5% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): +1.3% / +1.6%<br/>31 °C<sup>d</sup> (1 / 4 / 8 weeks): +0.2% / −5.2% / −17.2% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): +0.6% / +1.9% </p> <p>37 °C<sup>d</sup> (1 week): −15.4% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): −0.7% / −2.0% / −2.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): +2.1% / −1.7% / −0.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): +0.8% / −1.8% / −1.4%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): −1.5% to + 0.6%</p> <p>23 °C (28 days): −1.9% to +1.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): +1.0% to +2.5%</p> <p>23 °C (28 days): +0.7% to +4.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): −0.2% to 2.4%</p> <p>23 °C (28 days): −1.0% to −1.7%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: insulin potency<sup>a</sup> measured by HPLC, mass spectrometry, radioimmunological activity</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shaken for 72 hours at 37 °C and at ambient temperature: same molecular insulin weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (26 weeks): −0.069% total protein/week<br/>37 °C (26 weeks): –1.184% total protein/week<br/>Direct sunlight (26 weeks): −0.749% total protein/week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22–24 °C (42 days): 12 min peak 93% of baseline AUC reference; 21 min peak 94% of baseline AUC reference </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 °C (6 weeks): −3.1 IU/mL (95% CI 4.0)<br/>30 °C (10 weeks): −4.0 IU/mL (95% CI 4.9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 °C (6 weeks): −1.0 IU/mL (95% CI 1.9)<br/>30 °C (10 weeks): −1.4 IU/mL (95% CI 2.3) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a><sup>e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (86 days): 98.6 U/mL (CV 5.5%)<br/>22 °C (86 days): 99.4 U/mL (CV 5%)<br/>37 °C (86 days): 98.7 U/mL (CV 4.6%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> and 37 °C<sup>d</sup> (28 days): potency within specifications </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> and 37 °C<sup>d</sup> (28 days): potency within specifications; agglomerates (37 °C<sup>d</sup>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> and 37 °C<sup>d</sup> (28 days): potency within specifications; agglomerates (37 °C<sup>d</sup>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29.7 °C (28 days): −2.6% to +1.4% (compared to baseline AUC)<br/>37 °C (28 days): −1.5% to +0.7% (compared to baseline AUC) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (2 weeks): no change in potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3–5 °C (28 days): 93.3% (SD 2.4) AUC of initial concentration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: protein structure, formation of amyloid material</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): tridimensional structure verified </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): tridimensional structure verified </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): tridimensional structure verified </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C and 37 °C (5 weeks): no amyloid particles, large amorphous agglomerates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C and 37 °C (5 weeks): no amyloid particles, large amorphous agglomerates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): altered conformation or multimerisation in a minor fraction of the insulin molecules </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): altered conformation or multimerisation in a minor fraction of the insulin molecules </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26.3–28.9 °C (1 / 2 / 4 months): altered conformation or multimerisation in a minor fraction of the insulin molecules </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (cartridges/pens)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C (10 weeks): small changes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="top"> <p><b>Outcome: sterility, microbial contamination</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (vials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shaken for 72 hours at 37 °C and at ambient temperature: no bacterial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unopened</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): no microbial contamination </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): no microbial contamination </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>c</sup> (4 / 12 weeks): no microbial contamination </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opened (some samples)</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Short‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intermediate‐acting insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Premixed short‐acting/NPH insulin (prefilled syringes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Container</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): no microbial growth</p> <p>23 °C (28 days): no microbial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): no microbial growth</p> <p>23 °C (28 days): no microbial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (28 days): no microbial growth</p> <p>23 °C (28 days): no microbial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C (10 days): no bacterial growth</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>— denotes not investigated.</p> <p><sup>a</sup>US Pharmacopeia (USP) stipulates that human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL, i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin.<br/><sup>b</sup>Concentration of the short‐acting insulin in the biphasic insulin formulation.<br/><sup>c</sup>Oscillating temperatures.<br/><sup>d</sup>Continuous temperature.<br/><sup>e</sup>Mean insulin concentration (with CV) across all measurements and 86 days.<br/>AUC: area under the curve; CI: confidence interval; CV: coefficient of variation; HPLC: high‐performance liquid chromatography; NPH: neutral protamine Hagedorn; SD: standard deviation; U: unit. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Published in‐vitro studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD015385-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">In‐vitro data from pharmaceutical manufacturers</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from BIOTON<sup>a, b</sup>: human insulin potency compared to baseline (mean % change (SD) of several insulin batches)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="3" rowspan="2" scope="col" valign="bottom"> <p><b>25 °C storage</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>1 month</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>3 months</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>6 months</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>Short‐acting insulin (100 IU/mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>−1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>−1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>−1.7</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="3" rowspan="2" scope="col" valign="bottom"> <p><b>30 °C storage</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>28 days</b> </p> </th> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="bottom"> <p><b>42 days</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="5" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Short‐acting insulin (40 IU/mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>−2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>−2.0</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from Eli Lilly and Company<sup>c</sup>: human insulin (100 IU/mL) potency</b> </p> </th> </tr> <tr class="separated"> <td align="" class="headercell" colspan="3" rowspan="1" valign=""></td> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Storage before start use</b> </p> </th> <th align="center" class="headercell" colspan="5" rowspan="1" scope="col" valign="bottom"> <p><b>Patient in‐use</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>&lt; 25 °C (short‐acting, intermediate‐acting, mixed insulin)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Up to 25 days</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>Up to 28 days</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p>&lt; 30 °C (short‐acting, intermediate‐acting, mixed insulin)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Up to 12 days</p> </td> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p>Up to 28 days</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from Sanofi</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="10" rowspan="1" valign=""> <p>Sanofi permanently discontinued the production of its human insulins Insuman rapid 100 IU/mL, Insuman rapid SoloStar 100 IU/mL, Insuman basal 100 IU/mL, Insuman basal SoloStar 100 IU/mL, Insuman comb 25 100 IU/mL and Insuman comb 25 SoloStar 100 IU/mL worldwide. Data provided by the manufacturer could not be included in this review. </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="10" rowspan="1" scope="col" valign=""> <p><b>Data from Novo Nordisk<sup>a, d</sup>: human insulin (100 IU/mL) potency compared to baseline (mean % change (SD) of several insulin batches)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>25 °C storage</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>1 month</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>3 months</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>6 months</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>12 months</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.4 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.5 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.8 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.8 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.5 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.2 (0.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−7.4 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−6.5 (0.5)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intermediate‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.7 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−0.5 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.2 (0.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.9 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−2.0 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−2.3 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.4 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−3.9 (NA)</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>37 °C storage</b> </p> </th> <th align="center" class="headercell" colspan="4" rowspan="1" scope="col" valign="bottom"> <p><b>1 month</b> </p> </th> <th align="center" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>2 months</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>3 months</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Vials</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Cartridges</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−2.2 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−2.8 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−5.7 (0.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−5.7 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−8.6 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−8.3 (0.8)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intermediate‐acting insulin</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−1.8 (0.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−1.4 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.8 (0.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−3.0 (NA)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>−5.3 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−4.7 (NA)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup>US Pharmacopeia (USP) stipulates that human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL, i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin.<br/><sup>b</sup>A21 desamido insulin, impurities, total zinc, metacresol and pH all remained within reference values.<br/><sup>c</sup>All product quality attributes met established acceptance criteria.<br/><sup>d</sup>Up to 6 months at 25 °C and up to 2 months at 37 °C high molecular weight proteins were within specifications. Appearance, visible particles or macroscopy, particulate matter, zinc, pH, metacresol and phenol complied with specifications. No data were available on bacterial endotoxins and sterility.<br/>IU: insulin units; NA: not applicable. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">In‐vitro data from pharmaceutical manufacturers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015385-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics (I)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Stated aim of study (quotes)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Country</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Type and brand of human insulin</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pilot clinical study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The purpose of our study was to demonstrate the possible effect on the bioactivity of insulin, following storage in a zeer, a semiporous clay pot containing water, in desert conditions." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saudi Arabia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neutral human insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In an attempt to challenge the findings of Carter and Heinemann, we set out to develop a high‐throughput (1 min/sample) high‐resolution MS method to quantify insulin content and stability in vials." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> <p>Insulin aspart</p> <p>Faster‐acting insulin aspart</p> <p>Insulin glargine</p> <p>Insulin lispro</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Infrared (IR) spectroscopy has been successfully utilized for secondary structure analysis in cases of protein misfolding and fibril formation." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin detemir</p> <p>Insulin aspart</p> <p>NPH insulin human</p> <p>Insulin lispro</p> <p>Insulin lispro NPH insulin</p> <p>Insulin glargine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The purpose of this study was to evaluate the immunologic and radioreceptor degradation of insulin storage in commercial plastic syringes." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin<br/>Porcine insulin<br/>Lente iletin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"First, how much insulin transformation had occurred in vials by the time patients had finished with them? Next what was the importance of temperature, light, agitation, and regular withdrawal of insulin on the rates of appearance of three groups of ITP (insulin transformation product)? Finally, how did rates of transformation in vials issued to patients compare with vials from the same batch stored in various laboratory environments?" </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UK</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> <p>Beef insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this work, therefore, the question addressed is whether commercially available insulin is stable under high oscillating ambient temperatures for a period of four weeks (28 days), which corresponds to the usual recommended period of use of most commercially available insulins upon opening of the vial or cartridge." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Switzerland</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Actrapid<br/>Insulatard<br/>Mixtard 30 <br/>Novorapid <br/>Lantus Solostar<br/>Humalog KwikPen<br/>Humalog KwikPen mix 25 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The aim of this study was to evaluate the sterility of insulin and syringes when they were kept under refrigeration for up to 10 days." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Israel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin <br/>Rapid‐acting insulin </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Investigates the effect of temperature on the stability of basal insulin at 28 days after opening." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Thailand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NPH insulins</p> <p>Insulin analogue</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"The objective of this study was to determine if U‐500 insulin is stable when stored in prefilled syringes at 4 °C for up to 28 days." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"On the background of the article by Carter and Heinemann and given the importance of insulin quality on patient outcomes, we evaluated insulin concentrations in vials from three different sources: (1) we analyzed insulin content and stability based on production batches covering 7 years of production, (2) we measured insulin content from the last three years of insulin samples returned to Novo Nordisk from patients in the United States because of concerns expressed by the patients, and (3) we reviewed data from 10 years of independent European Medicines Association (EMA) sampling and testing of products." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐acting insulin</p> <p>Intermediate‐acting insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this pilot study, we aimed to identify: (1) the potency of six 100 IU/mL insulins (vials of human soluble; Eli Lilly), human isophane (Eli Lilly), and human soluble–isophane (30:70; Novo Nordisk); and 3 mL cartridges of insulin aspart (Novo Nordisk), and two preparations of insulin glargine (Sanofi and Eli Lilly) stored unopened for 1–4 months in non‐refrigerated conditions in a real‐world setting during the summer in India, all compared with control samples of each insulin, which remained refrigerated; and (2) whether there was any difference in storage temperatures and changes in potency between samples stored within and outside clay pots. These insulins were chosen to include commonly used insulins." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin:</p> <p>Humulin R<br/>Humulin N<br/>Mixtard 30/70 </p> <p>Analogue insulin:<br/>Novorapid<br/>Lantus/Basaglar </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this study we investigated with High Performance Liquid Chromatography (HPLC) (reversed phase chromatography and gel‐filtration) the aggregational behaviour of pork and human soluble insulin formulations under variations of motion and temperature." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin</p> <p>Pork insulin</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this study, aspects of the test development have been addressed such as the test conditions, automation of physical stress testing, and results for different formulations." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin regular, NPH, biphasic (70/30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"To evaluate the stability of two long‐acting insulin formulations, Humulin 70/30 and Levemir, after 28 days." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin biphasic (70/30)</p> <p>Insulin detemir</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"In this work, we investigated the effects of temperature and intermittent handling on the formation of subvisible and submicrometer protein particles in commercial insulin formulations." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin H – regular H</p> <p>Human insulin N – regular N</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"This study was conducted to determine the stability of a variety of biosynthetic human insulin products, along with their preservatives, when stored in two commonly used plastic insulin syringes." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin regular, NPH, biphasic (70/30)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"… we undertook this study to compare the potency of human insulin from three different manufacturers after storing at different temperatures and durations." </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>India</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Human insulin regular, biphasic (30/70)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>IU: insulin unit; lab: laboratory; MS: mass spectrometric; NPH: neutral protamine Hagedorn. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics (I)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015385-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline characteristics (II)</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Injection and container device</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Temperature and storage conditions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurements</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (opened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0007"> <li> <p>Temperature: outside 38.3 °C; insulin zeer 26.6 °C; dry zeer 34.6 °C; insulin vials stored in the shade 35.3 °C; water zeer 26.7 °C; bathroom 26.4 °C; refrigerator 4 °C </p> </li> <li> <p>Storage period: 6 weeks</p> </li> <li> <p>Storage conditions: clay pot (zeer) containing water; dry zeer; insulin vials in the shade; water zeer; bathroom (air‐conditioned house); refrigerator </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Twice‐daily sampling of insulin 10 U (simulation of usage conditions)</i> </p> <p> <ul id="CD015385-list-0008"> <li> <p>Temperature readings on 12 occasions</p> </li> <li> <p>Plasma glucose measurements after intravenous injection of 0.1 U/kg bodyweight of regular insulin </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0009"> <li> <p>Temperature: 4 °C, 22 °C, 37 °C</p> </li> <li> <p>Storage period: 1–85 days</p> </li> <li> <p>Storage conditions: temperature‐controlled environments with electronic temperature monitoring (refrigerator or incubators) </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0010"> <li> <p>Mass spectrometry (insulin concentration)</p> </li> <li> <p>Screening for degradation products</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0011"> <li> <p>Temperature: 0 °C, 20 °C, 37 °C</p> </li> <li> <p>Storage period: up to 10 weeks</p> </li> <li> <p>Storage conditions: climatic exposure cabinets</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0012"> <li> <p>Infrared spectroscopy in combination with attenuated total reflection technique (comparison of protein structural changes) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0013"> <li> <p>Temperature: 4 °C</p> </li> <li> <p>Storage period: 1, 3, 7 and 14 days</p> </li> <li> <p>Storage conditions: refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0014"> <li> <p>Insulin radioimmunoassay (insulin potency)</p> </li> <li> <p>Radioreceptor assay (binding to hepatic insulin receptors)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (opened, some samples)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0015"> <li> <p>Temperature: 19–24 °C (room temperature in the dark), 18–25 °C (room temperature in daylight), 8–35 °C (in direct sunlight on a window sill), 37 °C (in the dark), 4 °C (in the dark), carried in the breast pocket of a shirt </p> </li> <li> <p>Storage period: 2, 4, 6, 8, 10, 14, 18 and 26 weeks</p> </li> <li> <p>Storage conditions: under environmental conditions in the laboratory</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Twice‐daily sampling (simulation of usage conditions)</i> </p> <p> <ul id="CD015385-list-0016"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0006" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16:1-17. [DOI: 10.1371/journal.pone.0245372]MakoniM . Insulin storage without refrigeration. Lancet Diabetes Endocrinology2021;9(4):202. [DOI: 10.1016/S2213-8587(21)00057-7]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials and cartridges/pens<br/>(opened, some samples) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0017"> <li> <p>Oscillating temperatures 25–37 °C; isothermal (continuous) temperatures 31 °C and 37 °C </p> </li> <li> <p>Storage period: oscillating temperatures 4 and 12 weeks; isothermal (continuous) temperatures 1, 2, 4 and 8 weeks </p> </li> <li> <p>Storage conditions: incubators replicating temperature fluctuations in the Dagahaley refugee camp (Northern Kenya); a series of mixed insulin vials were stored at ambient temperature in Kenya for 4 weeks of use by patients and brought back to Geneva for analysis </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>For some samples, insulin was taken out daily (simulation of usage conditions with dosages of 10 IU in the morning and 12 IU in the evening)</i> </p> <p> <ul id="CD015385-list-0018"> <li> <p>Insulin potency (RP‐HPLC coupled with UV detection)</p> </li> <li> <p>Secondary structure of insulin monomers (measuring circular dichroism)</p> </li> <li> <p>Residual insulin bioactivity by measuring insulin efficiency on insulin receptor and akt kinase activation (Akt) phosphorylation in hepatic cells </p> </li> <li> <p>Visual inspection</p> </li> <li> <p>Microbial contamination (by transmission electron microscopy)</p> </li> <li> <p>Phenol and metacresol concentration</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0019"> <li> <p>Temperature: 4 °C</p> </li> <li> <p>Storage period: 10 days</p> </li> <li> <p>Storage conditions: refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0020"> <li> <p>Sterility</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges/pens (opened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0021"> <li> <p>Temperature: mean 29.7 °C (2.8 SD), range 25.5–37.1 °C; 2–8 °C; 37 °C</p> </li> <li> <p>Storage period: 28 days</p> </li> <li> <p>Storage conditions: room; refrigerator; incubator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>2 units of insulin were discarded every day (simulation of usage conditions)</i> </p> <p> <ul id="CD015385-list-0022"> <li> <p>Insulin potency (ultra HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0023"> <li> <p>Temperature: 3–5 °C</p> </li> <li> <p>Storage period: 7, 14, 21 and 28 days</p> </li> <li> <p>Storage conditions: laboratory refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0024"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0025"> <li> <p>Temperature: 5 °C, followed by 30 °C</p> </li> <li> <p>Storage period: 30 months + 6 weeks (to mimic in‐use impact); 30 months + 10 weeks (4 weeks to mimic non‐recommended handling conditions + 6 weeks to mimic in‐use impact) </p> </li> <li> <p>Storage conditions: refrigerator + unspecified ("left at 30 °C")</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0026"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0027"> <li> <p>Temperature: 26.3–28.9 °C (clay pot in shaded area)</p> </li> <li> <p>Storage period: 1, 2 and 4 months</p> </li> <li> <p>Storage conditions: clay pot, open box, laboratory refrigerator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0028"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> <li> <p><sup>1</sup>H NMR </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0029"> <li> <p>Temperature: 37 °C, ambient temperature</p> </li> <li> <p>Storage period: 72 hours</p> </li> <li> <p>Storage conditions: shaking for 72 hours (75 or 150 rotations/min)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0030"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> <li> <p>Gel‐filtration chromatography</p> </li> <li> <p>Radioimmunological activity</p> </li> <li> <p>Bacterial growth after inoculation</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges/pens (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0031"> <li> <p>Oscillating temperatures (OT) 25–37 °C; continuous temperature (CT) 37 °C (combined with periodic daily agitation by specially constructed rotation devices) </p> </li> <li> <p>Storage period: OT 7, 14, 21, 8 days; CT 2, 5, 7, 9, 11, 14, 17, 21, 24, 28 days</p> </li> <li> <p>Storage conditions: incubator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Resuspensions were conducted twice daily on a mechanical device outside the incubator unit</i> </p> <p> <ul id="CD015385-list-0032"> <li> <p>Insulin potency (RP‐HPLC)</p> </li> <li> <p>Visual changes (optical phase‐contrast microscopy)</p> </li> <li> <p>Particle size determination</p> </li> <li> <p>Electrophoretic mobility measurements</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0033"> <li> <p>Temperature: 2–8 °C; 22–24 °C</p> </li> <li> <p>Storage period: 28, 35 and 42 days</p> </li> <li> <p>Storage conditions: refrigerator; room</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0034"> <li> <p>Insulin potency (HPLC)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0035"> <li> <p>Temperature: 4 °C, 37 °C</p> </li> <li> <p>Storage period: 35 days</p> </li> <li> <p>Storage conditions: refrigerator/incubator</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein structure:</p> <p> <ul id="CD015385-list-0036"> <li> <p>Dynamic light scattering: determination of oligomeric and particulate distribution of insulin </p> </li> <li> <p>Transmission electron microscopy: morphological characterisation of insulin HMWP</p> </li> <li> <p>Thioflavin T fluorescence: formation of amyloid material</p> </li> <li> <p>Size exclusion chromatography: analysis of insulin formulations</p> </li> <li> <p>Electrospray ionisation mass spectrometry analysis in conjunction with ion mobility: formation of aggregates due to chemical degradation </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0037"> <li> <p>Temperature: 3–5 °C; 22–23 °C</p> </li> <li> <p>Storage period: 1, 3, 7, 14, 21 and 28 days</p> </li> <li> <p>Storage conditions: refrigerator; room</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0038"> <li> <p>Insulin potency (HPLC)</p> </li> <li> <p>Metacresol and phenol concentrations</p> </li> <li> <p>Sterility</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials (probably unopened)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0039"> <li> <p>Temperature: 5 °C, 32 °C, 37 °C, 25 °C, 26 °C</p> </li> <li> <p>Storage period: 7, 14 and 28 days</p> </li> <li> <p>Storage conditions: refrigerator; room temperature; room temperature in summer; air‐conditioned room; mud pot </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015385-list-0040"> <li> <p>Insulin potency (HPLC)</p> </li> <li> <p>Blood glucose (rabbit test)</p> </li> </ul> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>Short‐acting insulin was withdrawn for commercial reasons by the manufacturer. </p> <p><sup>1</sup>H NMR: proton nuclear magnetic resonance spectroscopy; HMWP: high molecular weight protein; HPLC: high‐performance liquid chromatography; IU: insulin unit; (RP)‐HPLC: (reverse‐phase) high‐performance liquid chromatography; SD: standard deviation; U: unit; UV: ultraviolet. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Baseline characteristics (II)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015385-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Overview of data from study publications</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study type</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Type of insulin</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Injection and container device</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Maximum temperature</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Maximum storage period</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Main measurement(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Key results<sup>a</sup> </b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0001" title='Al ShaibiK , FalataW , SayesN , Al ShareefM , Al TaweelM , AbozenadahA , et al. Storing insulin in a clay pot in the desert causes no loss of activity: a preliminary report. Annals of Saudi Medicine1999;19(6):547-9. AryaSC . Insulin storage in a clay pot. Annals of Saudi Medicine2000;20(5-6):491. [DOI: 10.5144/0256-4947.2000.491]TevaarwerkGJ . Reply to "Insulin storage in a clay pot". Annals of Saudi Medicine2000;20(5-6):491-2. [DOI: 10.5144/0256-4947.2000.491a]'>Al Shaibi 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pilot clinical study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin in clay pot 26.6 °C<br/>Insulin in refrigerator 4 °C </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Plasma glucose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0002" title="BaechlerF , StettlerC , VogtB , BallyL , GroesslM . Concentration and chemical stability of commercially available insulins: a high-resolution mass spectrometry study. Diabetes Technology &amp; Therapeutics2020;22(4):326-9. [DOI: 10.1089/dia.2019.0412]">Baechler 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Up to 37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98.7 U/mL (CV 4.6%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0005" title="GregoryR , EdwardsS , YatemanNA . Demonstration of insulin transformation products in insulin vials by high-performance liquid chromatography. Diabetes Care1991;14(1):42-8. [DOI: 10.2337/diacare.14.1.42]">Gregory 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.184% total protein/week</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0122" title="KaufmannB , BoulleP , BerthouF , FournierM , BeranD , CigleneckiI , et al. Heat-stability study of various insulin types in tropical temperature conditions: new insights towards improving diabetes care. PLOS One2021;16(2):e0245372. [DOI: 10.1371/journal.pone.0245372]">Kaufmann 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 °C ‐ 37 °C<sup>b</sup><br/><br/><br/>37 °C<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 weeks<br/>1 week / 2 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency<br/>Microbial contamination<br/>Protein structure </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: 101.3% (SD 2.3)<br/>IAI: 101.6% (SD 8.9)<br/>MI: 101.9% (SD 3.5)<br/>MI: −15.4% / SAI: −12.5%<br/>No microbial contamination<br/>No changes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0010" title="MosesA , BjerrumJ , HachM , WaehrensLH , ToftAD . Concentrations of intact insulin concurs with FDA and EMA standards when measured by HPLC in different parts of the distribution cold chain. Journal of Diabetes Science and Technology2019;13(1):55-9. [DOI: 10.1177/1932296818783783]">Moses 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −4.0 IU/mL (95% CI 4.9)<br/>IAI: 1.4 IU/mL (95% CI 2.3) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0011" title="PendseyS , JamesS , GarrettTJ , NordAB , PendseyS , MalmodinD , et al. Insulin thermostability in a real-world setting. Lancet Diabetes Endocrinology2023;11(5):310-2. [DOI: 10.1016/S2213-8587(23)00028-1]">Pendsey 2023</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28.9 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency<br/>Protein structure </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −2.4%<br/>IAI: −0.7%<br/>MI: −1.4%<br/>Small changes </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0012" title="SchraderE , PfeifferEF . The influence of motion and temperature upon the aggregational behavior of soluble insulin formulations investigated by high-performance liquid-chromatography. Journal of Liquid Chromatography1985;8(6):1139-57. [DOI: 10.1080/01483918508067133]">Schrader 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency<br/>Bacterial growth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No changes<br/>No bacterial growth </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0014" title="SilvaMA , ChuongM , KerrS , CabreraA . Stability of two long-acting insulin formulations after 28 days. Journal of Pharmacy Practice &amp; Research2013;43(1):37-40. [DOI: 10.1002/j.2055-2335.2013.tb00213.x]">Silva 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93–94% AUC</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0015" title="Silva-JrH , AraújoTS , da Silva AlmeidaM , ScapinSM , LimaLM . Formation of subvisible particles in commercial insulin formulations. Colloids and Surfaces B: Biointerfaces2022;216:112566. [DOI: 10.1016/j.colsurfb.2022.112566]">Silva‐Jr 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein structure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Amorphous agglomerates (both at 4 °C and 37 °C)<br/>No changes in chemical stability </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −18%<br/>IAI: −14% </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0003" title="DelbeckS , HeiseHM . Quality assurance of commercial insulin formulations: novel assay using infrared spectroscopy. Journal of Diabetes Science and Technology2021;15(4):865-73. [DOI: 10.1177/1932296820913874]DelbeckS , HeiseHM . Systematic stability testing of insulins as representative biopharmaceuticals using ATR FTIR-spectroscopy with focus on quality assurance. Journal of Biomedical Optics2021;26(4):043001-16. [DOI: 10.1117/1.JBO.26.4.043007]">Delbeck 2021a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Protein structure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small changes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0008" title="KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Diabetes2018;67(Suppl 1):2. [DOI: 10.2337/db18-1008-P]KongmalaiT , PreechasukL , JunnuS , ManocheewaS , SrisawatC , SriwijitkamolA . The effect of temperature on the stability of in-use insulin pens. Experimental and Clinical Endocrinology &amp; Diabetes2021;129(9):683-8. [DOI: 10.1055/a-1010-5466]">Kongmalai 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>−1.5% to +0.7%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0013" title="ShnekDR , HostettlerDL , BellMA , OlingerJM , FrankBH . Physical stress testing of insulin suspensions and solutions. Journal of Pharmaceutical Sciences1998;87(11):1459-65. [DOI: 10.1021/js980074x]">Shnek 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI, IAI, MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cartridges</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25–37 °C<sup>b</sup><br/>37 °C<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Within specifications <br/>Visual changes (agglomerates) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0004" title="DunbarJC , SimonFA . Immunologic and biologic evaluation of insulin degradation following prolonged storage in plastic syringes. Pancreas1986;1(4):317-9. [DOI: 10.1097/00006676-198607000-00004]">Dunbar 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No changes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0007" title="KofflerM , Orni-WasserlaufR , GolaniN , BergerSA . Prefilled insulin syringes can be kept sterile for at least 10 days when kept under refrigeration. Journal of Diabetic Complications1992;6(3):207-8. [DOI: 10.1016/1056-8727(92)90038-m]">Koffler 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI, IAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sterility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No signs of bacterial growth</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0009" title="LullME , PiacentinoJJ , TrainaAN . Stability of U-500 regular insulin in prefilled syringes. Journal of the American Pharmaceutical Association2013;53(3):304-6. [DOI: 10.1331/JAPhA.2013.12164]">Lull 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93.3% (SD 2.4) AUC</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lab study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI<br/>IAI<br/>MI </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prefilled syringes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 °C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insulin potency</p> <p>Sterility</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAI: −1.9% to +1.7%<br/>IAI: +0.7% to +4.7%<br/>MI: −1.0% to −1.7% </p> <p>No microbial growth</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup>All insulin activity data refer to baseline (time zero). According to US Pharmacopeia (USP) human insulin should have a potency of 95% to 105% of the potency stated on the label, expressed in USP insulin human units/mL, i.e. human insulin labelled '100 U/mL' has to contain 95 U/mL to 105 U/mL of insulin <br/><sup>b</sup>Oscillating temperatures<br/><sup>c</sup>Continuous temperature </p> <p>AUC: area under the curve; CI: confidence interval; CV: coefficient of variation; IAI: intermediate‐acting insulin; IU: insulin unit; MI: mixed insulin (short‐acting + intermediate‐acting insulin); SAI: short‐acting insulin; SD: standard deviation; U: unit. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Overview of data from study publications</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015385-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Mean blood sugar levels in rabbits after intraperitoneal administration of regular human insulin stored at different temperatures for 24 days</span></div> <tbody> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Novo Nordisk human insulin (mean mg/dL (SEM))</b> </p> </th> </tr> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>5 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>25 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>26 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>32 °C</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>37 °C</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.6 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.3 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.1 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>107.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.8 (1.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.6 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.5 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.6 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.6 (1.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.8 (1.8)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.8 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.3 (1.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.6 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.5 (0.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.8 (1.3)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Eli Lilly and Company human insulin (mean mg/dL (SEM))</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 (2.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.3 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.5 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 (1.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.6 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.5 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.6 (1.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.3 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.3 (1.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.8 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.8 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.1 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.8 (1.3)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.1 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.1 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.0 (0.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.3 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.8 (1.2)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>BIOCON human insulin (mean mg/dL (SEM))</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.3 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 (1.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.1 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 (1.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.8 (1.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.8 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.5 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.3 (1.9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.5 (1.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.5 (1.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.6 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.8 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.5 (1.1)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.0 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.0 (1.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.6 (1.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.3 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.0 (1.1)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Data from table in <a href="./references#CD015385-bbs2-0017" title="VimalavathiniR , GitanjaliB . Effect of temperature on the potency &amp; pharmacological action of insulin. Indian Journal of Medical Research2009;130(2):166-9. ">Vimalavathini 2009</a>. </p> <p>min: minutes; SEM: standard error of the mean.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Mean blood sugar levels in rabbits after intraperitoneal administration of regular human insulin stored at different temperatures for 24 days</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015385-tbl-0008"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Stability of human insulin formulations in plastic syringes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Temperature</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Initial concentration</b> (units/mL) <b>(mean ± SD)</b> </p> </th> <th align="center" class="headercell" colspan="6" rowspan="1" scope="col" valign=""> <p><b>Stability of human insulin in plastic syringes: % initial concentration remaining (mean ± SD)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 1</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 3</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 7</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 14</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 21</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Day 28</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Short‐acting human insulin (Humulin R)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.3 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.3 ± 1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.8 ± 3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.6 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.5 ± 3.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.3 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.6 ± 4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.0 ± 2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.2 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.9 ± 1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 1.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.0 ± 1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.1 ± 1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.4 ± 1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.6 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.7 ± 2.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 0.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.8 ± 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.1 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.2 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.1 ± 5.2</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Intermediate‐acting isophane human insulin (Humulin N)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.1 ± 1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 ± 2.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.4 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.1 ± 2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.0 ± 2.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.4 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.0 ± 0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.8 ± 1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.5 ± 3.6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105.0 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.3 ± 3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.2 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.3 ± 2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.9 ± 3.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 2.3</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.4 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.2 ± 2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.7 ± 3.6</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Mixed human insulin: short‐acting human insulin + intermediate‐acting human insulin (Humulin N/R 70/30)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.7 ± 5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.6 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.9 ± 7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.1 ± 2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.8 ± 3.1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.6 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.0 ± 5 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 3 8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104.8 ± 6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.4 ± 2.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.2 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.7 ± 3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98 9 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.7 ± 4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.0 ± 1.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.9 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.4 ± 1.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 3.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 2.9</p> </td> </tr> <tr> <th align="" class="headercell" colspan="8" rowspan="1" scope="col" valign=""> <p><b>Extemporaneous mixed insulin: intermediate‐acting human insulin + short‐acting human insulin (Humulin N/R 70/30)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.5 ± 2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.6 ± 3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.4 ± 5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.6 ± 2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.6 ± 4.4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (4 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.2 ± 2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.2 ± 1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97.4 ± 4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.3 ± 6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96.2 ± 3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.6 ± 3.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>T (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.2 ± 5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.0 ± 4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98.3 ± 7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103.7 ± 6.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96.9 ± 2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 2.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P (23 °C)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.7 ± 2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101.5 ± 4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0 ± 4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102 5 ± 5.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.5 ± 6.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102.8 ± 3.0</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Data from table 1 in <a href="./references#CD015385-bbs2-0016" title="TarrBD , CampbellRK , WorkmanTM . Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. American Journal of Hospital Pharmacy1991;48(12):2631-4. ">Tarr 1991</a> </p> <p>P: Plastipak (polypropylene); SD: standard deviation; T: Terumo (propylene‐ethylene copolymer). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Stability of human insulin formulations in plastic syringes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015385.pub2/full#CD015385-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD015385.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD015385-note-0010">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD015385-note-0021">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD015385-note-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD015385-note-0020">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD015385-note-0017">Hrvatski</a> </li> <li class="section-language"> <a class="" href="id#CD015385-note-0019">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD015385-note-0016">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD015385-note-0015">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD015385-note-0014">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD015385-note-0013">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD015385-note-0011">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD015385-note-0012">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015385\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015385\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015385\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015385\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015385\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015385.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD015385.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD015385.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD015385.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015385.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716838979"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD015385.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716838982"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD015385.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da94bcf551be3',t:'MTc0MDcxNjgzOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 